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ABSTRACT 
 
DANIEL TIMOTHY SWEET: The Adaptor Protein Shc is a Critical Regulator of 
Angiogenic and Shear Stress Signaling in Endothelial Cells 
(Under the direction of Ellie Tzima) 
 
 Endothelial cells (ECs), which form the lining of blood vessels, actively 
participate in many aspects of cardiovascular development and pathologies such 
as cancer and atherosclerosis.  Vascular ECs are unique in the diverse array of 
signals that they are capable of sensing from soluble growth factors, immobile 
extracellular matrix (ECM) proteins and mechanical forces.  Studying EC 
responses to this array of signals will enhance our understanding of the etiology 
of prevalent diseases such as cancer and atherosclerosis and lead to improved 
treatments.   
 Shc is an evolutionarily conserved adaptor protein that mediates signaling 
cascades downstream of activated receptors and is essential for development of 
the cardiovascular system.  This dissertation focuses on defining the roles that 
Shc plays in EC responses to angiogenic cues and mechanical force.  
 Angiogenesis, the growth of new blood vessels from pre-existing vessels, 
is important during embryonic development as well as in adults for wound healing 
and tumorigenesis.  Using loss-of-function experiments in the mouse and 
   ii  
 zebrafish, we found that Shc is required for sprouting angiogenesis in vivo.  Shc 
mediates signaling from integrins and VEGF receptors which is required for 
haptotaxis, survival and sprouting.  Interestingly, Shc integrates VEGF and ECM 
signaling as VEGF-induced survival requires Shc specifically on fibronectin.    
 Fluid shear stress, the frictional force from blood flowing over ECs, 
regulates EC function and allows vessels to respond to changes in tissue 
physiology but also contributes to vessel pathogenesis such as atherosclerosis.  
We have shown that Shc is required for transducing shear stress signaling 
directly downstream of the ‘mechanosensory complex’.  Shc is required for 
induction of the inflammatory response that is activated by disturbed shear stress 
and underlies the development of atherosclerotic plaques. Additionally, Shc is 
required in mice for shear-induced collateral artery remodeling and arterial 
specification during arteriogenesis.   
 Together, Shc plays an important signaling function in ECs and enables 
ECs to dynamically respond to angiogenic and mechanical stimulation from their 
environment.
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CHAPTER I.  
INTRODUCTION 
 
PREFACE 
Parts of this chapter were adapted from a previously published review article 1.  I 
wrote the original manuscript and Ellie Tzima wrote and edited the final version of 
the manuscript. 
 
SIGNAL TRANSDUCTION IN ECs 
 Endothelial cells (ECs) are a specialized cell type that form the inner lining 
of blood vessels and are actively involved in many aspects of cardiovascular 
development and pathology.  Vascular ECs are quite unique in the diverse array 
of signals that they are exposed to.  The constant flow of blood over the 
endothelium brings a myriad of soluble growth factors and cytokines that bind to 
receptors on the EC surface while also imparting mechanical forces that are 
sensed by the endothelium.  Signals from the surrounding ECM are sensed by 
integrins that form specific cell-ECM adhesions.  These signaling cascades are  
______________________________________ 
1 Sweet DT, Tzima E. Spatial signaling networks converge at the adaptor protein 
Shc. Cell Cycle. 2009 Jan 15; 8(2): 231-5
  
 required for important physiological EC functions, such as wound healing and  
inflammation, but also pathological EC functions, such as tumor angiogenesis 
and the chronic inflammation associated with atherosclerosis.  This dissertation 
has aimed to examine signal transduction pathways in ECs that are activated by 
angiogenic growth factors, mechanical force and the ECM.  By studying signal 
transduction in ECs, we will improve upon our current understanding of the 
causes of and potential treatments for prevalent diseases such as cancer and 
atherosclerosis.  My research has focused on the adaptor protein Shc, which we 
have found is an important mediator of EC signaling in response to angiogenic 
cues and mechanical force. 
 
ADAPTOR PROTEIN SHC 
The mammalian ShcA gene encodes three Shc isoforms of 46, 52 and 66 
kDa – all of which originate from the same mRNA either through alternative RNA 
splicing or translation initiation sites 1, 2.  The isoforms only differ in the length of 
their N-terminal CH2 domain and all three include the SH2 and PTB domains 
important in phospho-tyrosine receptor binding as well as the CH1 domain which 
houses three important tyrosine phosphorylation sites (see 3 for review).  Shc is 
ubiquitously expressed in adults 4 and has homologues in Drosophila and C. 
elegans, indicating an important evolutionarily conserved role for the protein 5, 6.  
Shc was initially described as an oncogene due to its key function in activation of 
Ras and MAPKs 1, 7-10.  Shc binds to phospho-tyrosine residues of activated 
Receptor Tyrosine Kinasas (RTKs) for growth factors such as Epidermal Growth 
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 Factor (EGF) 11, Platelet-Derived Growth Factor (PDGF) 12, 13, Insulin 14-17, and 
basic Fibroblast Growth Factor (bFGF) 18, 19.  When Shc binds activated RTKs, 
Shc itself is phosphorylated and then associates with secondary signaling 
molecules such as Grb2, which lead to activation of Ras 3.  Not only is Shc 
important in signaling from a variety of growth factor RTKs, but Shc also 
associates with and mediates signaling from a subset of integrins.  Activation of 
integrins α6β4 (laminin receptor), α1β1 (collagen/laminin receptor), 51 
(fibronectin) and αvβ3 (vitronectin/fibronectin) induces phosphorylation of Shc and 
Shc:integrin association.  Conversely, ligation of α2β1 (collagen/laminin), α3β1 
(promiscuous), α6β1 (laminin) and β2 integrins does not 20-22.  Shc has an 
established role in Ras signaling in non-EC tissues, but its role in EC signaling is 
less well defined. 
 Shc is critical for cardiovascular development, as Shc knockout mice are 
embryonic lethal at embryonic day 11.5 23  due to defects in heart development, 
as well as cell-cell contacts and mural cell coverage of the blood vessels.  
Further genetic studies revealed that Shc expression specifically in cardiac 
myocytes is sufficient for embryonic cardiovascular development and adult heart 
function 24, 25.  While a role for Shc in heart development and function has been 
established, relatively little is known about the role of Shc in the function of ECs.  
Shc has been implicated in signaling downstream of some EC-specific RTKs in 
vitro.  For example, Vascular Endothelial Growth Factor (VEGF) stimulation of 
ECs caused Shc to associate with VEGF Receptor-2 (VEGFR-2) and VE-
Cadherin 26, 27.  Similarly, Shc associates with integrins such as α5β1 and αvβ3 
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 that are required in ECs for proper angiogenesis 21, 28-30.  Because Shc 
associates with integrins and RTKs that are critical for angiogenesis and 
mechanotransduction, we hypothesized that Shc may act as a signaling hub in 
ECs. 
 
ANGIOGENESIS 
Blood vessels are formed through two sequential processes: 
vasculogenesis and angiogenesis. Vasculogenesis is the initial differentiation of 
endothelial cells from precursors and assembly into vessels whereas 
angiogenesis is a process of new vessel growth by sprouting from the existing 
vasculature 31-33.  Angiogenesis is important during embryonic development for 
proper patterning of the vascular tree as well as in adults for wound healing and 
during tumorigenesis.  Angiogenesis is a highly coordinated sprouting and 
remodeling process that is controlled by several signaling pathways such as Tie2 
and Notch, but the VEGF pathway is the principal master regulator of 
angiogenesis.  VEGF-A (referred to as simply VEGF) is a soluble growth factor 
whose expression is upregulated in hypoxic or cancer tissue to stimulate 
angiogenesis.  VEGF binds its receptor VEGFR-2 which is expressed specifically 
on the surface of ECs and activates multiple signaling cascades such as MAPKs, 
phospho-inositide 3-kinases (PI3Ks), Akt, and small GTPases such as RhoA.  As 
a result, VEGF signaling promotes EC proliferation, survival, migration towards 
the VEGF gradient, filopodia extension and EC permeability by disrupting 
adherens junctions and inducing endocytosis of VE-Cadherin 34, 35.  As the 
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 nascent vessel sprouts from the parent vessel, the underlying ECM is remodeled 
and integrins α5β1 and αvβ3 are upregulated in angiogenic ECs.  While the role of 
these integrins is controversial, it is clear that blocking either of these integrins 
can impede the angiogenic process 29 therefore proper function of integrins α5β1 
and αvβ3 is necessary in angiogenic ECs.   
 
MECHANOTRANSDUCTION: ECs RESPOND TO MECHANICAL FORCE 
Vascular ECs are constantly exposed to hemodynamic forces due to 
blood flowing over them.  Fluid shear stress, the frictional drag force from blood 
flow, is crucial in determining the shape, cytoskeletal organization and function of 
ECs and allowing vessels to respond to changes in tissue physiology but also 
contributing to vessel pathogenesis 36-38.  Although systemic risk factors such as 
smoking, diabetes, and high plasma levels of cholesterol and lipoproteins are 
associated with the development of atherosclerosis, atherosclerosis is a focal 
disease and forms preferentially at vessel bifurcations and curvatures- sites 
where blood flow is disturbed or turbulent 39.  In regions of arteries where flow is 
low (<5 dynes/cm2) and disturbed, atherosclerosis is promoted because 
disturbed flow increases proliferation and inflammation 40, 41.  These inflammatory 
processes also lead to a reduction in ‘protective’ functions such as endothelial 
Nitric Oxide Synthase (eNOS) expression, vasodilation and endothelial repair 36.  
In contrast, vessels with steady, laminar flow are protected from atherosclerotic 
plaque formation 41 and exhibit a phenotype in which the ECs are quiescent and 
align their cytoskeleton in the direction of flow.  Shear stress promotes either an 
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 atherogenic or atheroprotective EC phenotype, which underlies the development, 
or lack, of atherosclerotic plaque formation and therefore studying how ECs 
sense and respond to shear stress is a critical health care priority. 
Shear stress is detected by a variety of molecular force sensors located 
throughout the EC membrane 39, 42.  Forces from the apical (luminal) surface are 
transmitted through the cytoskeleton to points of attachment that resist shear 
stress 41. In that regard, both cell-cell and cell-ECM adhesions have been 
implicated in shear stress signal transduction.  At cell-cell adhesions, our lab has 
previously reported a ‘mechanosensory complex’ comprised of PECAM-1, VE-
Cadherin and VEGFR-2 which is necessary and sufficient for a subset of cellular 
responses to shear stress 43.  Indeed, PECAM-1 is required for cytoskeletal 
alignment to flow as well as atherosclerosis and flow-mediated vessel remodeling 
in vivo 43-46.  At the basal EC surface, integrins have also been implicated in 
mechanotransduction.  Shear stress stimulates the conversion of integrins to a 
high affinity state, followed by their binding to the ECM and subsequent activation 
of multiple signaling pathways downstream of integrin activation 47-49.  
Interestingly, the activation of the inflammatory transcription factor NF-κB by flow 
is dependent upon the ECM composition – as it is activated on fibronectin (FN) 
but prevented from being activated in cells growing on collagen (CL) 50, 51. 
EC responses to shear stress have been well characterized in vitro and 
can be divided into three categories temporally 38.  Rapid responses include 
production of vasodilator nitric oxide 52, 53 and phosphorylation of PECAM-1 54, 
VEGFR-2 55, and Akt by PI3K 56.  Also, at this early timepoint, integrins undergo a 
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 conformational activation and then these high-affinity integrins bind to their 
respective ligand in the underlying ECM 48.  On a time scale of minutes to hours, 
shear stress activates Rho family GTPases and initiates the process of 
cytoskeletal remodeling 48, 57-59, stimulates tyrosine phosphorylation of proteins 
such as MAPKs 60, release of Reactive Oxygen Species (ROS) 61 and activates 
transcription factors such as NF-B which are critical for initiating the 
inflammatory response to shear stress 62.  Slower responses that occur on a time 
scale of hours to days include altered expression of shear-responsive genes 
encoding Kruppel-like factor 2 (KLF2) 63, 64, eNOS, and cell adhesion molecules 
E-selectin, Intercellular Cell Adhesion Molecule (ICAM)-1 and Vascular Cell 
Adhesion Molecule (VCAM)-1 65, 66.  The hallmark of the long-term adaptive EC 
response to laminar shear stress is the rearrangement of actin microfilaments 
and microtubules and their elongation in the direction of flow 67-69, while long-term 
disturbed flow induces chronic inflammation and causes leukocyte adhesion and 
transmigration into the vessel wall 67, 70.  
 
ARTERIOGENESIS 
Shear stress regulates vessel size (caliber) whereas pressure determines 
vessel wall thickness 71.  Shear force is dependent on vessel diameter, so 
arteries dynamically respond to changes in shear stress by remodeling inward or 
outward to compensate for the new shear environment 72, 73.  Following an 
arterial occlusion, shear-induced vascular remodeling is the driving force for 
recovery of perfusion to ischemic tissue during a process known as 
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 arteriogenesis 74.  Arteriogenesis describes the formation of mature arteries from 
pre-existent interconnecting arterioles after an arterial occlusion 75.  Artery-to-
artery connections, called collateral arteries, arise during development and act as 
a natural bypass mechanism to circumvent circulation in the case of a large 
artery occlusion 74, 76.    Following an arterial occlusion, blood is re-routed into 
pre-existing collaterals, dramatically increasing shear stress and inducing 
outward remodeling, allowing the vessel to carry more flow and restore 
circulation to downstream ischemic tissue.  The sudden increase in collateral flow 
is sensed by ECs and activates several signaling pathways that are critical for 
vessel remodeling including proliferation of ECs and smooth muscle cells, vessel 
dilation via NO production, and inflammation and leukocyte transmigration into 
the vessel wall via the NF-B pathway 74, 77.  Arteriogenesis is critical to prevent 
tissue death following myocardial infarction or other arterial occlusion, and 
understanding this process will help in treatment and prevention of 
cardiovascular disease, the number one cause of death in industrialized nations 
such as the United States.   
 
RESEARCH PRESENTED IN THIS DISSERTATION 
 As described in the subsequent chapters, the overarching goals of this 
dissertation are as follows: 
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 Chapter II.  
Determine the role of the adaptor protein Shc in EC signaling during 
angiogenesis.  Previous studies have shown that Shc can bind to activated 
VEGFR-2 or integrins αvβ3 and α5β1.  Because these transmembrane receptors 
have been implicated in controlling angiogenesis, I hypothesized that Shc plays 
a role in angiogenesis by mediating signaling from one or both of these signaling 
hubs.  Using loss-of-function studies in mouse and zebrafish, I first assessed a 
possible role for Shc in angiogenesis in vivo.  Next, I performed a series of 
functional assays in vitro to test which EC functions are regulated through Shc 
signaling.  Finally, I uncovered the molecular mechanism by examining the role 
of Shc in mediating signaling pathways that are known to be required for 
angiogenesis.   
 
Chapter III. 
Determine the role of Shc in EC responses to shear stress.  Our lab recently 
reported a ‘mechanosensory complex’ in ECs that is necessary and sufficient for 
conferring cells the ability to respond to shear stress.  I hypothesized that Shc 
mediates signaling downstream of this ‘mechanosensory complex’ and therefore 
is required for mechanotransduction in ECs.  First, I performed in vitro 
experiments in ECs to test the role of Shc in mediating signaling from the 
‘mechanosensory complex’.  I then confirmed these findings in mice in which Shc 
is conditionally removed from ECs.  The role of Shc in shear stress-induced 
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 arteriogenesis was examined, focusing on inflammation and arterial specification, 
which underlie collateral vessel remodeling during arteriogenesis. 
 
Chapter IV. 
Synthesize the findings of the research chapters and assess the impact of 
these findings on the field of vascular biology. The findings of this 
dissertation represent several important contributions to the understanding of 
angiogenesis, arteriogenesis and EC signaling in general.  I briefly outlined the 
novelty and significance of my research and its implications in the future of 
cardiovascular research. 
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 Figure 1.1: ECs integrate diverse environmental signals from multiple cell-
surface receptors 
 
Endothelial Cells (ECs) use cell-surface receptors to sense a diverse array of 
signals which direct specific EC responses.  Soluble growth factors and cytokines 
secreted from surrounding tissue are sensed by Receptor Tyrosine Kinases 
(RTKs).  Also, mechanical force such as shear stress from blood flowing over the 
EC layer is sensed by a ‘Mechanosensory Complex’ comprised of VE-Cadherin 
and VEGFR2 located at cell-cell junctions.  Third, the composition of the 
Extracelular Matrix (ECM) is sensed by integrins at the basal surface of the cell. 
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CHAPTER II. 
 
THE ADAPTOR PROTEIN SHC INTEGRATES GROWTH FACTOR 
AND ECM SIGNALING DURING POSTNATAL ANGIOGENESIS 
 
PREFACE 
 This work was previously published in Blood in early 2012 1.  My role in 
this project included initiating the study and designing the experiments.  I 
performed all experiments and data analysis, wrote the manuscript and prepared 
the figures.  Zhongming Chen provided technical assistance with tissue staining.  
David M. Wiley and Victoria L. Bautch provided the protocol, reagents and 
assistance with the Fibrin Bead assay (Figure 2.3).  Ellie Tzima was the principal 
investigator of the study and designed the experiments, analyzed the data and 
wrote the manuscript. 
 
OVERVIEW 
 Angiogenesis requires integration of cues from growth factors, ECM 
proteins and their receptors in endothelial cells.  Here, we show that the adaptor 
_______________________________________ 
1 Sweet DT, Chen Z, Wiley DM, Bautch VL, Tzima E. The adaptor protein Shc 
integrates growth factor and ECM signaling during postnatal angiogenesis. 
Blood. 2012 Feb 23; 119(8): 1946-55. 
  
  protein Shc is required for angiogenesis in zebrafish, mice, and in cell culture 
models. Shc knockdown embryos show defects in intersegmental vessel 
sprouting in the zebrafish trunk.  Shc flox/flox; Tie2-Cre mice display reduced 
angiogenesis in the retinal neovascularization model and in response to VEGF in 
the Matrigel plug assay in vivo.  Functional studies reveal a model whereby Shc 
is required for integrin-mediated spreading and migration specifically on 
fibronectin, as well as EC survival in response to VEGF.  Mechanistically, Shc is 
required for activation of the Akt pathway downstream of both integrin and VEGF 
signaling as well as for integration of signals from these two receptors when cells 
are grown on fibronectin.  Thus, we have identified a unique mechanism in which 
signals from two critical angiogenic signaling axes, integrins and VEGFR-2, 
converge at Shc to regulate postnatal angiogenesis.   
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 INTRODUCTION 
Angiogenesis, the sprouting and growth of new blood vessels from pre-
existing vasculature, is critical for wound healing and in diseases such as 
rheumatoid arthritis, diabetes and cancer 1.  Angiogenesis is a highly coordinated 
tissue remodeling process activated by proangiogenic growth factors, such as 
VEGF, whose expression is upregulated in hypoxic or cancer cells.  VEGF 
receptors expressed on the EC surface become activated when bound to the 
VEGF ligand, and initiate signaling cascades that lead to EC proliferation, 
migration, survival and tube formation 2.  Basement membrane deposition and 
mechanical cues from the extracellular matrix transmitted via integrins also 
participate to coordinate vessel sprouting and remodeling in conjunction with the 
VEGF signaling pathway 3.  Given their transmembrane structure, ability to form 
associations with adaptor molecules and ability to bind to extracellular ligands, 
VEGF receptors and integrins are well positioned to serve as functional hubs 
during the angiogenic process 4. 
 Adaptor proteins, which have no catalytic activity but instead promote 
protein-protein interactions, are important regulators of signaling pathways 
downstream of activated cell-surface receptors 5.  The prototypical adaptor 
protein Shc is an evolutionarily conserved, ubiquitously expressed protein that 
was originally described as an oncogene because of its participation in the 
activation of Ras and MAPKinases downstream of a multitude of receptors for 
various growth factors, cytokines and hormones 6, 7.  Shc is expressed as three 
isoforms of 46, 52 and 66 kDa, all of which are products of the same gene, Shc1 
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 8, 9.  Global knockout of Shc1 in mice causes embryonic lethality at E11.5 10.  
These embryos exhibit severe defects in the cardiovascular system, including 
defective heart development and vessel remodeling.  More detailed gene 
targeting work has shown that expression of the PTB domain of Shc specifically 
in cardiomyocytes is critical for mid-gestational heart development and 
embryonic life 11.  Conditional knockout strategies have shown that Shc is also 
important for the proper development/function of other organs such as skeletal 
muscle11, brain 12 , cardiomyocytes 13 and thymocytes 14, as tissue specific 
deletion of Shc resulted in living, but mis-developed mice. To address the role of 
Shc in angiogenesis in vivo, we studied loss of Shc function using morpholino 
antisense technology in zebrafish.  Additionally, we used the Tie2-Cre transgene 
to generate mice null for Shc in ECs and some hematopoietic cells 15. 
Surprisingly, these mice survive through development, thus enabling us to 
investigate the role of Shc in postnatal angiogenesis.  Here, we show that Shc is 
required for proper angiogenesis in vivo in both the zebrafish and mouse.  
Mechanistically, Shc is required for transmitting signals downstream of two major 
angiogenic signaling hubs, VEGFR-2 and integrins. 
 
METHODS 
Zebrafish Morpholino Injection 
Two splice-blocking morpholinos targeting the zebrafish ortholog of Shc 
(accession # LOC563639) were designed by GeneTools.  The MO sequences 
are: ShcMO1: 5’- TGAAATGAATTGAATCTTACCCTGA -3’ and ShcMO2: 5’-
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 ATAAAGAATTGGAAACCTTTCTCCT -3’.  ShcMO2 resulted in better Shc 
knockdown and was used for experiments.  Shc or Standard Control morpholinos 
were injected into one-cell-stage Tg(kdrl:egfp) zebrafish embryos at 8 ng (2x) or 
16ng (4x) per embryo.  Embryos were scored and imaged at 24 hpf stage by 
embedding in 1% agarose solution with 0.016% tricaine to inhibit movement.  Z-
stacks were taken using 5x and 20x objectives on a Zeiss Pascal confocal 
microscope.  Control 4x MO n=118; Shc 2x MO n=72; Shc 4x MO n=105 
embryos.  Numbers indicate all fish counted from 3 independent experiments.   
 
Mice 
Shc floxed mice were a kind gift from Dr. Kodi Ravichandran at University of 
Virginia16.  Tie2-Cre (B6.Cg-Tg(Tek-cre)12Flv/J) and R26R (B6.129S4-
Gt(ROSA)26Sortm1Sor/J) mice were purchased from Jackson Labs.  All 
housing, breeding and experimental procedures using mice were in accordance 
with national guidelines and regulations and were approved by the Institutional 
Animal Care and Use Committee at the University of North Carolina- Chapel Hill.   
 
X-gal Stain of R26R Tissue 
The Rosa26 Reporter mice (Jackson Labs) were used to monitor expression of 
Tie2-Cre.  Male Shcflox/flox; Tie2-Cre+ were mated with female R26R mice to 
produce Shcflox/+; R26R+; Tie2-Cre+ and Shcflox/+; R26R+ offspring.  Four 
week old mice were euthanized and tissues were quickly frozen and sectioned 
into 5um slices.  Frozen sections were fixed in 0.2% gluteraldehyde and stained 
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 overnight with 1mg/ml X-Gal and then counterstained with Nuclear Fast Red.  
Slides were imaged using the 4x, 10x and 40x objectives on an Olympus BX61 
light microscope.  Representative images are shown. 
 
Matrigel Plug Assay 
4-6 week old littermates were used to assay angiogenesis from subcutaneous 
tissue into Growth Factor Reduced Matrigel (BD Biosciences).  Cold matrigel was 
mixed with heparin (50 U/ml; Sigma) and VEGF (250 ng/ml) or vehicle (ddH2O). 
Mice were lightly anaesthetized using isofluorane and cold matrigel (0.5 ml) was 
injected into the abdominal subcutaneous tissue along the peritoneal mid-line. 
After 7 days, mice were euthanized and matrigel plugs were removed and fixed 
in 4% paraformaldehyde, embedded in paraffin, sectioned and H&E stained.  
Blood vessel infiltration into the plug was quantified in 4 sections per plug, each 
100μm apart, by counting number of cells per mm2 using ImageJ software.  
Images were obtained on an Olympus BX61 light microscope and expressed as 
mean values of 5-6 mice per condition. 
 
Mouse Lung Endothelial Cell Isolation 
Mouse Lung Endothelial Cells (MLECs) were isolated from 6-9 day old 
Shcflox/flox and Shcflox/flox; Tie2-Cre+ littermate mice.  Lungs were dissected 
from the mouse and were gently minced, collagenase digested, triturated and 
strained. The resulting single cell suspension underwent positive cell selection 
using rat anti mouse PECAM-1 (BD Pharmingen) antibody conjugated magnetic 
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 Dynabeads (Invitrogen). PECAM-positive cells were plated in tissue culture 
flasks coated with 10μg/mL fibronectin and cultured in EGM-2 (Lonza).  ECs 
were immortalized by transduction with Polyoma Middle T antigen expressing 
retrovirus, and selected using G418.  Four clones per genotype were isolated 
and validated for expression of endothelial markers VEGFR-2, VE-Cadherin and 
PECAM-1.  Cells were cultured in EGM-2 (10% FBS). 
 
Fibrin Gel Bead assay 
Fibrin Gel Bead Assays were performed following the previously published 
protocol17.  In short, MLECs were incubated with dextran-coated Cytodex 3 
microcarriers (Amersham Pharmacia Biotech) at a concentration of 400 cells per 
bead in 1.5 ml of EGM-2 medium (Lonza) for 4 h at 37°C.  The following day, 
cell-coated beads were washed with EGM-2 and resuspended in 2 mg/ml 
Fibrinogen (Sigma) solution plus 0.15 U/ml aprotinin (Sigma) at a concentration 
of 500 cell-coated beads/ml in 2.5 mg/ml.  500 microliters of fibrinogen/bead 
solution was added to 0.625 units of thrombin (Sigma) per well of a glass bottom 
24-well tissue culture plate.  Cultures were grown for 3 days in EGM-2 (10% 
FBS) and fixed in 4% PFA on day 3.  Cells were stained with Phalloidin (FITC) to 
visualize actin and DRAQ5 to mark EC nuclei and imaged using an Olympus 
FLV500 inverted confocal microscope using the 10x and 40x objectives.  Sprouts 
were quantitated by counting # sprouts per bead and # nuclei per sprout.  
Sprouts were defined as protrusions containing 2 or more nuclei and >15 beads 
were counted per genotype. 
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 Endothelial Cell Culture & Lentivirus Infection 
Human umbilical vein endothelial cells were purchased from Lonza and 
maintained in M199 supplemented with 10% Fetal Bovine Serum, 30ug/mL 
Endothelial Cell Growth Supplement, 100ug/mL Heparin and 1x Pen/Strep (all 
purchesd from Sigma).  HUVECs were starved in M199 media with 0.5% FBS 
and 1x Pen/Strep for 4 hours before using in experiments unless noted.  HUVEC 
were used between passage 2 and 9.   
shRNAs against Shc or non-specific control were designed by Dharmacon 
and subcloned into pLentiLox 5.0 vector for production of lentivirus in 293T cells 
as previously described18.  shShc target sequence 
GGGGAGGAGTAACCTGAAA targets all 3 isoforms of the human Shc1 gene.  
Control shNS sequence GATCGACTTACGACGTTAT has no match in the 
human, mouse or rat genomes. 
 
Cell Spreading Assay 
HUVECs were detached with trypsin, washed with PBS and kept in suspension 
for 30 minutes in the starvation medium. An equal number of cells were plated in 
Starvation medium on glass coverslips coated in 10ug/ml fibronectin, 10ug/ml 
collagen (Millipore) or PBS. After 25 minutes, cells were fixed with 2% 
formaldehyde, permeabilized with 0.2% Triton X-100 and stained with Alexa-
Fluor-568-conjugated phalloidin to mark actin. Fluorescent images of randomly 
selected fields were acquired using a Zeiss Axiovert S100 and spread area was 
measured using the threshold function of ImageJ software (NIH).  Values shown 
   26  
 are mean +/- SEM (n=2 independent experiments, >100 cells counted per 
condition per experiment).   
 
Cell Migration Assays 
Haptotaxis and chemotaxis to VEGF assays were performed using Boyden 
Chambers (Transwells– Corning) with 8 μm pores.   
Haptotaxis experiments – The underside of the Transwell filter was coated in 
either 10ug/ml fibronectin or collagen or PBS for 2 hr at 37◦ C.   
Chemotaxis experiments – Both the top and bottom of the filters were coated 
with 10ug/ml fibronectin for 2 hr at 37 C.Filters were washed in PBS and then 
blocked in PBS+3% BSA for 1 hr at 37◦ C and then washed again.  HUVECs 
were FACS sorted to obtain a pure population of GFP-positive cells, and 10,000 
cells were loaded into the upper portion of each chamber.  After 4 hr incubation, 
filters were washed 2x in cold PBS and non-migrating cells were removed from 
top of chamber with a cotton swab.  Filters were fixed in 2% formaldehyde and 
migration was quantitated by blind counting the number of migratory cells on the 
lower surface of the membrane using an inverted Zeiss Axiovert S100 
microscope.  Five random fields were imaged per filter.  Values shown are mean 
+/- SEM (n=3 independent experiments, 2 filters per condition per experiment). 
 
EC Survival Assay 
Lentivirus-infected HUVEC were seeded on FN or CL coated dishes and cultured 
in Full HUVEC media for 1 day.  ECs were starved for 24 hr in Starvation media 
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 supplemented with 100ng/ml VEGF (Millipore) or vehicle control to induce 
apoptosis.  After 24 hr, media was removed and cells were washed 1x with PBS 
to remove floating cell debris and lysed for western blot.  Values shown are mean 
+/- SEM (n=4 independent experiments) 
 
Retinal EC Proliferation Assays 
Proliferating cells were marked using the Click-iT EdU kit (Invitrogen) following 
manufacturer instructions.  100 mg/g EdU was injected intraperitoneally into each 
P5 pup. Two hours later, pups were anaesthetized with isofluorane and 
euthanized by injection of 2% Paraformaldehyde into the left ventricle to fix 
vessels.  Retinas were dissected out and fixed in 4% PFA and then stained with 
Isolectin B4 (Sigma) to mark ECs, DAPI to mark nuclei and EdU to mark 
proliferative nuclei.  Flatmounted retinas were imaged using a Zeiss LSM 710 
confocal microscope – 20x and 60x objectives.  Images were analyzed using 
ImageJ (NIH) to count either number of branchpoints per 100 μm2 or % of 
proliferative nuclei by dividing the number of EdU-positive, isolectin-positive 
nuclei by the total number of isolectin positive nuclei.  For branchpoint analysis, 
Shcflox/flox n= 17; Shcflox/flox; Tie2-Cre+ n= 15 mice.  For proliferation analysis, 
Shcflox/flox n= 5; Shcflox/flox; Tie2-Cre n= 8 mice.   
 
EC Adhesion Assay 
Lentivirus infected HUVEC were starved for 4 hours and then removed from dish 
using 0.05% Trypsin-EDTA (Akt activation) or 20mM EDTA (ERK activation), 
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 spun down to pellet cells and resuspended in HUVEC starvation media.  Equal 
number of cells were seeded on dishes coated in FN or CL (10μg/mL) and 
allowed to adhere for 15 min (ERK activation) or 30 min (Akt activation) in 
incubator.  Non-adherent cells were washed away with PBS and adherent cells 
were lysed and processed for western blot.    
 
VEGF Treatments & Western Blot Analysis 
 Lentivirus infected HUVEC were grown to confluence on FN coated dishes 
and starved for 4 hours.  Media was removed from all dishes and replaced with 
fresh starvation media supplemented with 100ng/ml VEGF (Millipore) or vehicle 
control.  Cells were incubated for 5 minutes, then washed 1x in PBS and were 
lysed in buffer containing 1% Noniodet P-40, 150 mM NaCl, 50 mM Tris-HCL (pH 
7.8), 2 mM EDTA, 10 mM NaF, 10 mM Na2P2O7, 2mM Na3VO4 10 μg/mL 
leupeptin, 4 μg/mL pepstatin and 0.1 U/mL aprotinin.  Lysates were cleared by 
spinning at max speed in a tabletop centrifuge and supernatant was combined 
with 10x Lamelli Sample Buffer and boiled briefly.  Lysate was loaded into a 4-
12% NuPage Bis-Tris gel and run according to manufacturer instructions using 
the Licor Odyssey system.   
Zebrafish were lysed in buffer containing 1% Noniodet P-40, 150 mM 
NaCl, 50 mM Tris-HCL (pH 7.4), 1 mM EGTA, 0.25% Deoxycholate, 10 mM NaF, 
2mM Na3VO4, 1mM PMSF, 10 μg/mL leupeptin, and 0.1 U/mL aprotinin.  15 fish 
per condition were homogenized in a tissue tearor and lysate was cleared as 
described above. 
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 Antibodies used:  α -Shc (BD Transduction), α -GAPDH (Millipore), α - 
Cleaved Caspase 3 (Cell Signaling).  Intensity of bands was quantified using 
ImageJ and protein intensity was divided by GAPDH to normalize for total protein 
concentration.  Quantification is shown as the mean of >3 experiments. 
 
Quantification & Statistical Analysis 
Band intensity of immunoblots was quantified using the ImageJ program. 
Each experimental group was analyzed using single factor analysis of variance. 
P-values were obtained by performing two-tailed Student’s t test using 
Excel. Statistical significance was defined as P < 0.05. 
 
RESULTS 
Angiogenesis in Zebrafish Requires Shc 
A role for Shc in patterning of the vascular system and sprouting 
angiogenesis was assayed by depleting Shc protein from zebrafish embryos.   
Sprouting of Intersegmental Vessels (ISVs) dorsally from the aorta is a VEGF-
driven process that can easily be visualized in situ using transgenic zebrafish 19.  
Shc protein was depleted from Tg(kdrl:egfp) zebrafish embryos at the 1 cell 
stage using a splice-site blocking morpholino (MO) targeted against Shc (data 
not shown).  Shc-MO did not induce zebrafish death, suggesting that Shc is not 
required for zebrafish embryonic development during the first 3 days post 
fertilization.  Interestingly, global Shc depletion in the zebrafish embryo caused 
angiogenesis defects specifically, while all other tissues appeared normal.  Shc 
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 morphants showed impaired ISV formation at 30 hpf (Figure 2.1A).  At high 
concentration of Shc-MO (16 ng/embryo) as well as low concentration 
(8ng/embryo), 73% and 55% of Shc-MO fish displayed a cardiovascular defect 
compared to only 12% of fish injected with high concentration of Standard 
Control-MO (Figure 2.1B).  The predominant vascular phenotype observed was 
defective growth of ISVs dorsally and improper Dorsal Longitudinal Anastamotic 
Vessel (DLAV) formation, while other defects ranged from complete loss of ISV 
sprouts or abnormal overall ISV patterning (termed “Severe CV Defects”) to 
dilated Caudal Ventral Vein and partial connection of ISVs to DLAV (“Mild CV 
Defects”).  In all conditions, a small percentage of zebrafish exhibited non-
cardiovascular (CV) defects such as gross defects in head, eye, fin or tail 
morphology.  We believe this is a non-specific effect of accidentally injuring the 
embryo with the micropipette during morpholino injection.  No obvious defects 
were observed in heartbeat, aorta morphology or overall zebrafish patterning, 
indicating a specific role for Shc in angiogenesis during zebrafish development.  
These results are consistent with the phenotype of the global Shc knockout 
mouse, which exhibited cardiovascular development defects 10.  In contrast to the 
mouse, Shc-MO zebrafish did not display increased lethality compared to 
Control-MO injected fish.  This apparent discrepancy may be due to the unique 
ability of zebrafish to survive significantly longer than mice without a functional 
heart or vascular system 20 and/or the incomplete depletion of Shc protein in the 
Shc-MO zebrafish.  The zebrafish genome is known to have undergone 
extensive genome duplication, however it appears that the Shc gene has 
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 escaped this duplication, and only a single Shc gene exists in zebrafish.  The 
morpholinos used here target unique sequences at the locus LOC563639 and 
nowhere else in the zebrafish genome.  While we cannot rule out the existence of 
another un-anottated Shc-like gene playing a redundant or unique role in 
zebrafish development, nobody has reported such a gene. 
 
Endothelial Shc is Required for Proper Angiogenesis in vivo 
To specifically inactivate the Shc1 gene in ECs, female mice carrying 
floxed alleles of Shc exons 1 and 216 were intercrossed with male transgenic 
mice expressing Cre recombinase under the control of the Tie2 promoter which 
is expressed specifically in ECs and some hematopoietic cells 15.  In this cross, 
the Tie2-Cre allele was always donated from the father to minimize leakage of 
Cre expression into other tissues, which can occur when Tie2-Cre is donated by 
the mother.  Surprisingly, Shcflox/flox; Tie2-Cre+ were born at the expected 
Mendelian ratio and these animals display no gross anatomic abnormalities or 
decrease in fertility compared to Shcflox/flox controls.  To verify tissue specific 
Cre/loxP recombination in our mice, we crossed Shcflox/flox; Tie2-Cre+ mice to 
mice the Rosa26 Lac-Z Reporter allele.  X-gal staining of the carotid artery, heart 
and retina showed staining restricted to the endothelium (data not shown).  Cre 
expression was not mosaic, as X-Gal staining was seen in nearly all ECs.  To 
confirm that Shc protein was reduced in ECs, primary lung ECs were isolated 
from Shcflox/flox; Tie2-Cre+ and Shcflox/flox littermates.  Western blot analysis 
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 revealed a complete reduction in all three Shc isoforms in the Shcflox/flox; Tie2-
Cre+ animals (data not shown). 
To determine whether angiogenesis is affected in Shcflox/flox; Tie2-Cre+ 
animals, we used two in vivo models: neonatal retinal neovascularization and the 
Matrigel plug assay.  Vascularization of the murine retina commences after birth, 
as the vessels originating at the optic nerve spread radially over the inner surface 
of the retina on the pre-existing template of astrocytes, guided by a gradient of 
VEGF-A to form a two-dimensional vascular plexus 21.  At postnatal day 5, 
retinas were isolated and stained with Isolectin B4 to mark ECs.  Shcflox/flox; 
Tie2-Cre+ mice exhibited a less dense primitive plexus at the vascular front 
compared to both Shcflox/flox and Shc wt/wt; Tie2-Cre+ controls (Figure 2.2A).  
Vascular density in the retina was quantified by counting the number of 
branchpoints per 100 μm2 area as well as % vascular area, both of which 
revealed a significant decrease in Shcflox/flox; Tie2-Cre+ compared to littermate 
controls (Figure 2.2A, lower).  Both genotypes of control mice, Shcflox/flox and 
Shc wt/wt; Tie2-Cre+, showed equal retinal vascular density, indicating Tie2-Cre 
expression itself if not responsible for the phenotype, so only Shcflox/flox 
littermate controls were used in the remaining experiments.   
The Matrigel plug assay, in which microvessel growth is induced toward 
an angiogenic factor source (in this case VEGF), adult mice were injected with 
two plugs each, one containing vehicle and the other supplemented with VEGF 
to induce angiogenesis into the plug.  VEGF induced neovascularization of 
Matrigel implants in Shcflox/flox controls, whereas neovascularization was 
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 impaired in Shcflox/flox; Tie2-Cre+ littermates (Figure 2.2B).  Collectively, these 
data suggest that endothelial Shc is required for proper postnatal angiogenesis in 
vivo.  
 
Endothelial Shc is Required for Tube Assembly & Sprouting in vitro 
To further determine the role of Shc in the EC angiogenic response, we 
performed the Fibrin Gel Bead assay.  The Fibrin Gel Bead assay was preferred 
over other available in vitro angiogenesis assays because this assay involves 
actual sprouting of ECs off of the bead over a period of a few days so EC 
proliferation, migration and survival are required; whereas standard ‘tube 
formation’ assays largely involve assembly of ECs into capillary-like tubes over a 
timecourse of a few hours, so the processes of proliferation, survival and 
sprouting are less important.  Secondly, fibrin gel is more applicable because it is 
made of digested fibrinogen, and Shc has previously been shown to bind to 
fibrinogen-binding integrins such as α5β1 and αvβ3 whereas the standard Matrigel 
is a complex mixture of several ECM proteins such as collagen, laminin and 
others.  ECs isolated from the lungs of Shcflox/flox; Tie2-Cre+ and Shcflox/flox 
mice (MLECs) were coated on beads and embedded in Fibrin gel.  Control 
Shcflox/flox ECs sprouted outward off the bead and lumenized to form capillary-
like vessels in the 3D Fibrin matrix, as is typically seen using HUVEC.  
Interestingly, Shcflox/flox; Tie2-Cre+ MLECs displayed a striking defect in both 
number and size of sprouts (Figure 2.3A).  While Shcflox/flox; Tie2-Cre+ MLECs 
were able to extend filopodia out into the matrix at a normal or even enhanced 
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 rate, these filopodia failed to develop into full sprouts and the tip cells remained 
stuck on the bead.  Quantification revealed a significant reduction in number of 
sprouts per bead as well as number of cells per sprout, indicating an important 
role for Shc in EC sprouting (Figure 2.3B). 
 
Shc is Required for Integrin-Mediated EC Signaling 
 To understand the mechanism underlying the role for Shc in angiogenesis, 
we examined signaling downstream of two major angiogenic receptors: integrins 
and VEGFR-2 in ECs.  Previous work has shown that Shc binds to a subset of 
activated integrins and mediates signaling.  Upon outside-in integrin activation by 
ligation to its ECM ligand, Shc is phosphorylated and recruited to integrins α5β1 
(fibronectin receptor) and αvβ3 (fibronectin/vitronectin), but not to α2β1 (collagen) 
or α6β1 (laminin) 22.  We therefore tested the role of Shc in integrin-dependent 
angiogenic responses.  For the following experiments, Human Umbilical Vein 
Endothelial Cells (HUVECs) were infected with lentivirus that expresses either 
Shc (shShc) or non-specific (shNS) shRNA in order to deplete Shc protein (data 
not shown).  The role of Shc in integrin-mediated cell spreading on ECM was 
tested by seeding equal numbers of ECs on fibronection (FN) or collagen (CL) 
and measuring the cell area.  While there was no difference in spreading on CL 
in the absence of Shc, Shc-depleted ECs showed impaired spreading on FN 
compared to control ECs (Figure 2.4A), suggesting that Shc is required 
specifically for EC spreading on FN.  To determine whether migration toward FN 
also required Shc, we performed haptotaxis assays using Boyden Chambers.  
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 Similar to the spreading experiments, EC migration toward FN was impaired in 
Shc-depleted ECs, while migration toward CL occurred independent of Shc 
(Figure 2.4B)  These results indicate that Shc is required for integrin-mediated 
spreading and migration towards FN, therefore suggesting that Shc selectively 
mediates angiogenic signaling downstream of FN-binding integrins. 
  
Shc is Required for VEGF-Mediated EC Signaling 
 VEGF induces Shc phosphorylation and its association with VEGFR-2 and 
VE-Cadherin 23, 24.  However, the role of Shc, if any, in signaling downstream of 
VEGF remains unexplored.  We assayed the role of Shc in VEGF-induced EC 
survival and migration in vitro, as well as proliferation of retinal ECs in vivo.  EC 
survival was assayed by inducing apoptosis in ECs in the presence or absence 
of VEGF.  Apoptosis was quantified by measuring the level of cleaved caspase 3 
present in the cell lysates.  VEGF treatment resulted in a 50% decrease in 
cleaved caspase 3 in shNS control cells, while shShc ECs showed no significant 
protection from apoptosis (Figure 2.5A).  To determine the role of Shc in VEGF-
induced migration, we assayed chemotaxis toward a VEGF gradient.  Baseline 
migration of both shNS and shShc ECs was similar, and interestingly, migration 
toward VEGF was induced in both cell types, indicating that Shc is not required 
for EC migration toward a VEGF gradient (Figure 2.5B).  In the developing retina, 
vessel outgrowth occurs by proliferation of ECs and migration of endothelial tip 
cells in response to the VEGF gradient released from the underlying astrocytes 
25.  To investigate if Shc deficiency affects the proliferation rate of retinal ECs, we 
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 analyzed EdU (5-ethynyl-2’-deoxyuridine) incorporation into endothelial nuclei 2 
hours after injection into the P5 mice (Figure 2.5C).  Retinas were stained to 
mark ECs green (Isolectin), all cell nuclei blue (DAPI) and proliferating cells red 
(EdU).  By comparing the number of cells that stained positive for all three 
markers divided by the total number of ECs, we found the number of EdU-
positive EC nuclei was slightly lower in Shcflox/flox; Tie2-Cre+ mice compared to 
controls (Figure 2.5C), but these differences did not reach statistical significance. 
Thus, Shc does not play a significant role in EC proliferation.  Together, these 
data are consistent with a model in which Shc function is important for survival 
signaling in response to VEGF, but not for VEGF-induced migration or 
proliferation. 
 
Integration of VEGF & integrin signaling via Shc 
Our data show a role for Shc in processes downstream of both VEGF and 
integrins.  We hypothesized that Shc mediates crosstalk between these two 
receptors.  To test this hypothesis, we performed survival experiments on ECs 
plated on FN vs CL.  VEGF treatment resulted in a ~50% decrease in apoptosis 
in shNS control cells grown on either FN or CL, similar to what was seen in 
Figure 2.5A.  Interestingly, shShc ECs grown on CL showed similar VEGF-
induced survival as control shNS cells, while shShc ECs grown on FN showed no 
significant protection from apoptosis (Figure 2.6).  These data suggest that Shc 
integrates VEGF and integrin signals specifically on FN. 
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 Shc Mediates Akt Activation Downstream of VEGF & Integrin Activation 
To further delineate the signaling pathways that are mediated by Shc 
downstream VEGF and integrin signaling, we assayed activation of two key 
signaling cascades, Akt and ERK 1/2.  shShc ECs treated with VEGF failed to 
activate Akt, whereas VEGF-induced ERK 1/2 activation was similar to shNS 
control ECs (Figure 2.7A).  Interestingly, the requirement for Shc in the activation 
of Akt was specific to VEGF, as Epidermal Growth Factor (EGF) induced robust 
activation of Akt in both shNS and shShc ECs (data not shown).    
Similarly, Akt activation by adhesion of ECs to FN was impaired in shShc 
ECs, whereas shShc ECs plated on CL could activate Akt normally (Figure 2.7B), 
indicating that Shc mediates Akt activation specifically downstream of FN binding 
integrins.  In contrast, ERK 1/2 was activated similarly in both shNS and shShc 
ECs on both FN and CL, indicating that Shc is not important for ERK 1/2 
activation downstream of either FN or CL binding integrins.  Together, these data 
are consistent with a model in which Shc function is important for Akt signaling 
which promotes survival downstream of VEGF specifically on FN, whereas Shc is 
dispensable for ERK 1/2 activation and EC proliferation. 
 
 
 
DISCUSSION 
In this study, we present evidence that the adaptor protein Shc is required 
for postnatal angiogenesis in zebrafish, mouse and cell culture models.  Shc 
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 morphant zebrafish embryos show defects in ISV sprouting in the trunk, while 
Shcflox/flox; Tie2-Cre+ mice display impaired angiogenesis in the retina and in 
the Matrigel plug assay in vivo.  Using an in vitro model of angiogenesis, we 
show that Shc is required for sprouting and tube formation.  Mechanistically, Shc 
integrates signaling downstream of integrins and VEGF.  Shc is required for 
integrin-mediated spreading and migration specifically on FN, as well as survival 
in response to VEGF.  Importantly, Shc integrates VEGF and integrin signaling, 
as VEGF-induced survival on FN requires Shc, whereas survival in ECs on CL 
does not.  Activation of the Akt, but not ERK1/2, pathway in response to both 
VEGF and integrin activation depends on Shc. Combined, these processes are 
critical for angiogenesis and provide a mechanism by which Shc integrates 
signals from VEGF and integrins to mediate angiogenesis (Figure 2.7C).  The 
observation that Shc is required for VEGF-induced EC survival is reminiscent of 
the reported role for VE-Cadherin in this process 51.  Indeed, it is likely that Shc is 
involved in signaling downstream of this VE-Cadherin:VEGFR-2 complex that 
leads to Akt activation and cell survival because the same lab later showed that 
VEGF treatment of ECs induces a Shc association with both VE-Cadherin and 
VEGF-2 23.  It is unknown whether Shc mediates assembly of the VE-Cadherin: 
VEGFR-2 complex or merely signals downstream of this complex after it is 
formed, but this will be an area of further research. 
 Given the large number of signaling networks that need to be organized 
and integrated for new vessels to form, signaling hubs may be important during 
angiogenesis 4.  In this manner, both integrin and VEGF- receptor complexes 
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 represent central signaling axes during angiogenesis.  Activation of either 
VEGFR-2 or αvβ3 induces physical association of the two receptors, which is 
important for VEGFR-2 phosphorylation 26.  Function of both receptors is required 
for proper signaling, as inhibition of αvβ3 or VEGFR-2 function decreases 
VEGFR-2 activation and complex formation27, 28.  Our work here shows that Shc 
is required for mediating and integrating angiogenic responses downstream of 
both integrins (FN-binding integrins specifically) and VEGF, thus coordinating the 
angiogenic process as a whole.   
Shc was originally described as an oncogene, and mutation of Shc 
attenuates tumor growth in mice 29.  Shc overexpression in fibroblasts causes 
transformation 9 and Shc is required for cellular transformation in ErbB2-
overexpressing breast cancer cells 30, as well as in mammary tumors induced by 
Polyoma Middle T expression 31.  In humans, clinical studies have associated 
Shc activation with poor patient prognosis 29.  These data, combined with our 
current findings, suggest that Shc is critical for many steps of tumorigenesis, 
including cellular transformation of tumor cells themselves, as well as 
angiogenesis in ECs that feed the tumor and enable its growth.  Therefore, Shc 
may be an interesting target for cancer treatment at multiple levels. 
 Expression of the PTB-domain of Shc in cardiomyocytes is essential for 
embryonic heart development 11.  Interestingly, mice with a conditional deletion of 
Shc in specific organs such as skeletal muscle 11, thymocytes 14, or brain12 live to 
adulthood, exhibiting defects only in the function of the tissue in which Shc was 
removed.  Similarly, we now show that endothelial Shc expression is not required 
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 for embryonic development, but it is required postnatally for angiogenesis.  
Induction of Tie2-Cre expression has been reported at E9.515, which precedes 
embryonic lethality of the global Shc knockout at E11.5, so mis-timing of Shc 
gene excision does not appear to be the reason for Shcflox/flox; Tie2-Cre+ 
mouse survival.    Emerging research has set precedence for the idea that 
conditional gene knockout using the Tie2-Cre transgene can result in mice that 
initially develop a normal vasculature while exhibiting defective angiogenic 
capacity.  Tie2-Cre mediated conditional knockout of genes such as Endothelin-
132, 33, TFPI34, ADAM1735, PPARγ 36 and Dicer 37 yield viable mice with 
cardiovascular defects, while the corresponding global knockout animal is 
embryonic lethal.  Thus, genes such as Shc and others appear to have differing 
roles in developmental vs. postnatal angiogenesis.  This hypothesis is 
strengthened in light of the literature on proteins that interact with Shc.  Our 
results indicate that Shc is required for signaling downstream of FN-binding 
integrins such as αvβ3 and/or α5β1, which are upregulated during angiogenesis.  
Surprisingly, endothelial knockout of αv38, β339, or α540 results in viable mice, while 
antagonism of either of these integrins using blocking antibodies results in a 
defect in angiogenesis41-43.  We also show that Shc mediates a subset of 
signaling responses downstream of VEGF.  In particular, Shc is required for EC 
survival but not proliferation in response to VEGF.  
We recently reported a role for Shc in mechanotransduction in response to 
shear stress 44.  Hemodynamic forces are emerging as an important regulator of 
angiogenesis in some vascular beds such as aortic arch 45, 46 and yolk sac 47 in 
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 both mouse and fish.  Flow also promotes hematopoetic cell development 48, 49 in 
vivo and atheroprotective laminar flow inhibits HUVEC tubule formation and 
migration in vitro 50.  Therefore, a role for Shc in flow-driven angiogenesis is an 
attractive idea.  Integration of VEGF- and flow dependant signaling was recently 
reported during zebrafish vascular remodeling 46, and future experiments are 
aimed at understanding the role of Shc in these processes.  Angiogenesis 
involves a complex interplay of mechanical forces, ECM remodeling and pro- and 
anti- angiogenic growth factors, all signaling simultaneously in ECs.  Adaptor 
proteins, such as Shc, are likely responsible for the integration of these signals 
due to their ability to bind many receptors, and are emerging as signaling nodes 
critical for many vascular processes. 
 
   42  
 Figure 2.1: Shc is required for intersegmental vessel sprouting 
angiogenesis in zebrafish 
 
(A)  Shc protein depletion in Tg(kdrl:egfp) zebrafish embryos results in defective 
angiogenesis 30 hpf.  Representative images of trunk vasculature are shown, 
with anterior on the left.  Shc-MO fish exhibited a range of vascular phenotypes, 
the most common being delayed or defective intersomitic vessel sprouting and 
growth dorsally from the aorta.  Scale bars = 200 μm.  (B) Quantification of 
phenotypes observed in all living fish at 24 hpf displayed as % of total.  Control 
4x MO n=118; Shc 2x MO n=72; Shc 4x MO n=105 embryos.  Numbers indicate 
all fish counted from 3 independent experiments. 
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 Figure 2.2: Endothelial Shc knockout causes defective angiogenesis in vivo  
 
(A)  Shc knockout in ECs results in decreased vascular density in the postnatal 
retina.  Retinas from P5 mice were stained with Isolectin-B4 Alexa488 to 
visualize endothelial cells.  Vascular density was quantified by counting 
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 branchpoints per 100 μm2 and % vascular area - performed blind by two different 
people.  Shcflox/flox n= 17; Shcflox/flox; Tie2-Cre+ n= 15 ; Shc wt/wt;; Tie2-Cre+ 
n= 9 mice.  Scale bars = 100 μm.  (B)  Matrigel Plug assay in 4-6 week old mice 
reveals a role for EC Shc in angiogenesis toward VEGF.  Matrigel plugs 
containing 250 ng/ml VEGF and or vehicle alone were implanted into each 
mouse.  After 7 days, plugs were H&E stained and microvessels per mm2 were 
counted in serial sections through the plug.  Quantification is shown as mean +/- 
SEM (Student’s t-test).  Shcflox/flox n= 5, Shcflox/flox; Tie2-Cre+ n=6 mice.  
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 Figure 2.3: Endothelial Shc is required for tube assembly & sprouting in 
vitro 
 
(A)  Fibrin Gel Bead Assay was performed using MLEC isolated from mice used 
in Fig. 2.  On Day 3 after seeding cell covered beads in gel, cultures were fixed 
and stained for phalloidin (green) and DRAQ5 (blue).  Quantifications (below) 
were performed by counting at least 15 beads per genotype and are expressed 
as mean +/- SEM.  n= 2 independent experiments, 4 replicates per experiment.  
In all graphs, * indicates p<0.05  
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 Figure 2.4: Shc is required for integrin-mediated spreading & haptotaxis on 
fibronectin but not collagen  
 
(A)  Shc is required for cell spreading on FN.   Equal numbers of lentivirus 
infected HUVECs were seeded on coverslips coated with 10ug/ml FN, 10ug/ml 
CL or vehicle (PBS) and allowed to spread for 25 minutes. Cell area was 
measured using ImageJ.  Values shown are mean +/- SEM (n=2 independent 
experiments, >100 cells counted per condition per experiment).  (B)  Haptotaxis 
was measured using Boyden Chambers coated on the underside with 10ug/ml 
FN, 10ug/ml CL or vehicle (PBS) and blocked with 3% BSA.  Cells that had 
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 migrated to the underside of the chamber were counted using an inverted 
microscope.  Five random fields were imaged per filter.  Values shown are mean 
+/- SEM (n=3 independent experiments, 2 filters per condition per experiment).  
In all graphs, * indicates p<0.05 
   48  
 Figure 2.5: Shc is required for VEGF-induced EC survival but not migration 
toward VEGF or proliferation  
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 (A) HUVECs were serum starved for 24 hrs with or without 100ng/ml VEGF to 
induce apoptosis.  Lysates were immunoblotted for cleaved caspase 3 and 
GAPDH as a loading control.  Survival was quantified by comparing the amount 
of cleaved caspase 3 present in lysate.  Values shown are mean +/- SEM (n=4 
independent experiments).  (B) Chemotaxis toward VEGF gradient was 
measured using Boyden Chambers containing 100ng/ml VEGF or vehicle in the 
lower well.  After 4 hours of migration, cells that had migrated to the underside of 
the membrane were counted using an inverted microscope.  Five random fields 
were imaged per filter.  Values shown are mean +/- SEM (n=3 independent 
experiments, 2 filters per condition per experiment).  In all graphs, * indicates 
p<0.05.  (C) EC Proliferation was assayed in the P5 mouse retina.  EdU reagent 
was injected intraperitoneally and 2 hrs later retinas were harvested.  Retinas 
were stained with Isolectin (green) to mark ECs, DAPI (blue) to mark all cell 
nuclei, and EdU (red) to mark proliferating nuclei.  Proliferation of ECs was 
quantified by counting # isolectin/EdU positive nuclei divided by # isolectin/DAPI 
positive nuclei.  Values shown are mean +/- SEM (Shcflox/flox n= 5; Shcflox/flox; 
Tie2-Cre n= 8).   
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 Figure 2.6: Survival requires integration of VEGF & integrin signaling 
through Shc  
 
(A) HUVECs were seeded on FN or CL coated dishes, then serum starved for 24 
hrs with or without 100ng/ml VEGF to induce apoptosis.  Lysates were 
immunoblotted for cleaved caspase 3 and GAPDH as a loading control.  Survival 
was quantified by comparing the amount of cleaved caspase 3 present in lysate.  
Values shown are mean +/- SEM (n=3 independent experiments). 
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 Figure 2.7: Shc is required for specific signal transduction pathways 
downstream of integrins & VEGF  
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 (A) The role of Shc in VEGF signaling was assayed in HUVECs.  Cells were 
treated for 5 min with 100ng/ml VEGF or vehicle.  Cell lysates were separated by 
SDS-PAGE and immunoblotted for the indicated proteins.  Quantitation values 
shown are mean +/- SEM (n=4 independent experiments).  (B) The role of Shc in 
integrin signaling was assayed in HUVECs.  Cells were allowed to adhere and 
spread on FN or CL (10ug/ml) for kept as controls.  Cell lysates were separated 
by SDS-PAGE and immunoblotted for the indicated proteins.  Quantitation values 
shown are mean +/- SEM (n=3 independent experiments).  In all graphs, * 
indicates p<0.05 (C) Schematic model of how Shc is thought to regulate 
angiogenesis in endothelial cells.  Shc participates in signaling from fibronectin 
binding integrins such as αvβ3 and α5β1 which is required for EC spreading and 
migration.  Simultaneously, Shc is also required for EC survival induced by 
VEGF.  Loss of Shc results in attenuation of Akt activation by the integrin and 
VEGF pathways in ECs and thus, results in defective angiogenesis, as is seen in 
the zebrafish and mouse. 
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CHAPTER III. 
 
SHC MEDIATES THE ENDOTHELIAL RESPONSE TO SHEAR 
STRESS IN VITRO AND DURING ARTERIOGENESIS IN VIVO 
 
PREFACE 
 This chapter represents results described in two manuscripts.  The first 
manuscript, published in 2008 1, described a role for the adaptor protein Shc in 
the endothelial response to shear stress in vitro.  Some of the data from this 
paper is included in Figures 3.1-3.3 of this chapter.  I was the second author on 
this paper and my contributions included performing and analyzing the in vitro 
experiments showing Shc phosphorylation and Shc association with the 
mechanosensory complex in response to flow, and experiments comparing 
responses to flow on FN and CL.  Yunhao Liu performed mouse tissue 
immunohistochemistry and the Shc siRNA experiments.  Mohamad Irani-Tehrani 
performed initial co-immunoprecipitation experiments and made the discovery 
that Shc associates with VE-cadherin and integrins in response to shear stress.  
Nobuyo Maeda provided the ApoE null mice.  Ellie Tzima was the principal  
______________________________________ 
1 Liu Y, Sweet DT, Irani-Tehrani M, Maeda N, Tzima E. Shc coordinates signals 
from intercellular junctions and integrins to regulate flow-induced inflammation. J 
Cell Biol. 2008 Jul 14; 182(1):185-96 
  
 investigator of the study, designed the experiments, analyzed the data and wrote 
the manuscript. 
 The second manuscript, which encompasses Figures 3.4-3.7 of this 
chapter, is currently under review at Circulation Research 2.  This paper 
examines the role of Shc in shear stress-induced arteriogenesis in vivo.  I am co-
first author on this paper and contributed by making the conditional knockout 
mice, performing the Laser Doppler Imaging, imaging and quantitating tissue 
sections, performing qPCR experiments and writing the manuscript.  Zhongming 
Chen performed hindlimb ischemia surgeries, harvested mouse tissue and 
performed immunofluorescence staining and imaging of collateral sections.  Ellie 
Tzima was the principal investigator of the study, designed the experiments, 
analyzed the data and wrote the manuscript. 
 
OVERVIEW 
 Shear stress is a potent regulator of the EC phenotype and regulates the 
inflammatory status of the vessel.  Disturbed shear stress can trigger chronic 
vascular inflammation and cause atherogenic plaque formation, whereas 
increased shear stress through collaterals can be beneficial following an 
occlusion, when changes in shear stress can induce vessel remodeling and 
______________________________________ 
2  Sweet DT, Chen Z, Tzima E.  Endothelial Shc regulates arteriogenesis through 
dual control of arterial specification and inflammation via the Notch and NF-κB 
pathways.  In Review- Circulation Research 
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  recovery of perfusion of the ischemic tissue.  Shear stress is sensed by several 
different ‘mechanosensors’ at cell-cell and cell-ECM adhesions, however little is 
known about signal transduction downstream of these mechanosensors.  Here, 
we show that the adaptor protein Shc is activated by shear stress and associates 
with cell-cell and cell-matrix adhesions.  Shc regulates flow-induced inflammatory 
signaling by mediating NF-κB activation and subsequent leukocyte adhesion to 
the endothelium in vitro.  We confirmed that Shc is required for signaling in 
response to shear stress in vivo, as conditional knockout mice in which Shc is 
deleted from ECs exhibited reduced hindlimb perfusion recovery following 
femoral artery ligation.  Reduced perfusion was associated with blunted shear-
driven collateral remodeling and reduced capillary density.  Mechanistically, Shc 
deficiency resulted in impaired activation of the NF-κB-dependent inflammatory 
pathway and reduced CD45+ leukocyte infiltration into the vessel wall. 
Unexpectedly, Shc is required for arterial specification of the remodeling arteriole 
by mediating upregulation of the arterial endothelial cell marker ephrinB2 and 
activation of the Notch pathway.  Taken together, these results show that Shc is 
activated by shear stress and mediates activation of shear stress-induced 
signaling pathways such as inflammation and arterial specification. 
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 INTRODUCTION 
 Fluid shear stress, the frictional force from blood flow, acts directly on the 
endothelium to modulate vessel structure and function 1.  Two different types of 
shear stress exist due to the natural branched and curved patterning of the 
vascular tree.  In straight vessels such as the descending aorta, laminar flow 
exerts atheroprotective effects on the ECs by activating anti-inflammatory genes, 
such as eNOS and Klf-2.  Conversely, in curved or bifurcated regions of the 
vasculature such as the aortic arch, disturbed shear stress occurs and 
atheroprotective genes are suppressed, while pro-atherogenic genes are 
upregulated, thereby promoting the atherosclerotic process 2.  Importantly, acute 
onset of laminar flow in vitro stimulates many of the same responses as 
sustained disturbed shear.  However, over longer time periods, the cells adapt to 
the unidirectional laminar shear forces and downregulate signaling, whereas 
under prolonged disturbed shear, continual changes in flow magnitude and 
direction lead to chronic, sustained signaling3. Thus, the in vitro protocol in which 
cells under static conditions are exposed to an abrupt increase in flow has been 
widely used as a model for disturbed flow and is particularly useful in analyzing 
temporal responses to flow.  In vivo, onset of flow occurs in pre-existing collateral 
arteries acutely following occlusion of a large artery upstream, and initiates a 
shear-stress induced remodeling process called arteriogenesis. 
 Arteriogenesis, the outward remodeling of pre-existing immature collateral 
arteries, is critical in recovery and restoration of blood supply to ischemic tissue 
following a vascular occlusion.  Arteriole–arteriole anastomoses, termed 
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 collateral arteries, act as a natural bypass mechanism to maintain blood supply 
to downstream tissue even when major arteries, such as the femoral artery, 
become blocked 4.  In a healthy animal, blood flow through collateral arteries is 
negligible, however, after an occlusion, the steep pressure gradient between the 
pre-and post- occlusive regions of the vessel causes blood to rush into pre-
existing collaterals, activating ECs and inducing outward remodeling of the 
vessel.  Outward remodeling of pre-existing collaterals is driven primarily by the 
sudden spike in hemodynamic forces resulting from the increase in flow through 
the collaterals5.  Changes in hemodynamic forces are sensed by ECs6-8, which 
initiate signal transduction pathways that ultimately result in outward remodelling 
of the vessel to increase the lumen diameter and normalize the high shear 
stress.   
 EC surfaces are equipped with numerous mechanoreceptors that are 
capable of detecting and responding to shear stress 10, 11. After activation of 
mechanoreceptors, a complex network of several intracellular pathways is 
triggered, a process known as mechanotransduction.  We previously identified a 
‘mechanosensory complex’ located at cell-cell junctions comprised of PECAM-1, 
VE-Cadherin, and VEGFR-2 that is necessary and sufficient for the EC response 
to shear stress in vitro such as activation of NF-κB and it’s pro-inflammatory 
target genes12, vascular remodeling13 and arteriogenesis in vivo14.   
 The Shc1 gene encodes an adaptor protein which is a key component of 
the pathways that activate Ras and MAP kinases downstream of several different 
growth factors, cytokines, integrins and mechanical forces 15-18.  When activated, 
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 Shc associates with phospho-tyrosine residues on activated receptors, inducing 
Shc phosphorylation at tyrosine residues 239/240 and/or 317.  Shc 
phosphorylation allows association with other signaling molecules and activation 
of signaling cascades such as Ras/MAPK pathway 17.  In addition, tyrosine-
phosphorylated Shc associates with integrins α5β1 and αvβ3 when they are 
conjugated to appropriate ligands (FN) 19, 20.   Importantly, Shc is expressed 
primarily in the cardiovascular system of mouse embryos and global knockout of 
the Shc1 gene in mice causes embryonic lethality at E11.5 due to defects in 
embryonic heart development21, 22  
 Here, we show that shear stress induces association of Shc with 
components of the ‘mechanosensory complex’ and reveal a surprising role for 
Shc in flow-induced inflammatory signaling in vitro.  Additionally, Shc is required 
specifically in ECs for shear stress-induced arteriogenesis in vivo.  Our data 
show impaired plantar perfusion recovery in Shc flox/flox; Tie2-Cre conditional 
knockout mice compared to controls.  Furthermore, we demonstrate that Shc is 
required for ligation-induced inflammation and activation of the NF-κB pathway in 
collateral arteries.  Surprisingly, Shc is also required for shear stress-induced 
activation of the Notch pathway and downstream expression of the arterial 
marker ephrinB2, which is important for specifying arterial identity of the 
remodeling collaterals. 
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 METHODS 
BAEC Culture, Transfections & Shear Stress 
Bovine aortic endothelial cells (BAECs) were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM, Invitrogen) with 10% Fetal Bovine Serum (FBS, 
Invitrogen), 10 μg/ml penicillin, 0.25 μg/ml streptomycin (Invitrogen).  THP-1 
leukocytes were maintained in RMPI 1640 medium (Invitrogen) with 10% FBS, 
10 μg/ml penicillin, 0.25 μg/ml streptomycin, and 2 mM glutamate (Invitrogen).  
Control siRNA or Shc siRNA (Dharmacon) were transfected into BAECs as 
previously described23.  For shear stress experiments, BAECs were plated on 
appropriate matrix proteins (10 μg/ml FN or 20 μg/ml Coll I) and allowed to grow 
for 10 h in medium containing 10% FBS or 4h in 0.5% FBS.  Cells were then 
starved overnight in medium containing 0.5% FBS.  Slides were loaded onto a 
parallel plate flow chamber in 0.5% FBS and 12 dynes/cm2 of laminar shear 
stress was applied for indicated times.  To perform oscillatory flow, the slides 
were attached to parallel chambers as with laminar flow.  The chambers were 
subsequently connected to an NE-1050 bi-directional pump purchased from New 
Era Pump Systems, Inc. (Farmingdale, NY).  Cells were sheared at ± 6.5 
Dyne/cm2, 1 Hz in media containing 0.5% FBS. 
 
Immunoprecipitations, Western blotting & Antibodies 
Cells were harvested in lysis buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 1% 
Triton X-100, 0.1% SDS) supplemented with 1 mM aprotinin, 1 μg/ml leupeptin, 1 
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 mM PMSF, 1 mM Na3VO4, 10 mM NaF, 1 mM sodium pyrophosphate and 1 mM 
β-glycerophosphate.  Lysates were pre-cleared with 50 μl protein A/G plus 
sepharose beads (Santa Cruz) for 1 h at 4°C.  Supernatants were then incubated 
with 30 μl protein A/G plus sepharose previously coupled to the primary 
antibodies for 2 h at 4°C with continuous agitation.  The beads were washed 
three times with lysis buffer supplemented with protease and phosphatase 
inhibitors and the immune complexes were eluted in 2X SDS sample buffer.  
Associated proteins were subjected to SDS-PAGE and Western Blotting using 
the appropriate primary antibodies and HRP-conjugated anti-mouse or anti-rabbit 
antibodies (Jackson Immunochemicals).  Immunoreactive proteins were 
visualized by enhanced chemiluminescence (GE Health).  The phospho-Shc 
(Tyr239/240 or Tyr317) and phospho-p65 (Ser536) were purchased from Cell 
Signaling.  An anti-Shc phosphoTyr239/240 antibody from Invitrogen BioSource 
was tested and generated similar results to the Cell Signaling phospho-Shc 
antibody.  Anti-VEGFR-2 and VE-Cadherin antibodies were purchased from 
Santa Cruz Biotechnology.  Anti-Shc and anti-NFκB (p65) were purchased from 
BD Transduction Laboratories.  FITC-conjugated goat anti-mouse IgG and 
Rhodamine-conjugated goat anti-rabbit IgG were obtained from Jackson 
ImmunoResearch Inc. and used at 1:200 dilution. 
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 Immunofluorescence Microscopy 
To examine the tyrosine phosphorylation of Shc and the nuclear translocation of 
NFκB, cells were fixed for 20 min in PBS containing 2% formaldehyde, 
permeabilized with 0.2% Triton X-100, and blocked with PBS containing 10% 
goat serum and 1% BSA for 1h at room temperature.  Antibody incubations were 
performed as previously described24 and slides mounted in vectashield mounting 
medium (Vector laboratories, Inc.).  Images were obtained using the 60X/1.40 oil 
objective on a Nikon Eclipse E800 microscope equipped with a Hamamatsu 
ORCA-ER digital camera and MetaMorph software.  
 
Leukocyte Adhesion Assay 
For each adhesion assay, 1×106 THP-1 cells were collected by centrifugation.  
Cells were resuspended in serum-free RMPI 1640 medium containing 1 μM 
CellTracker Green CMFDA (5-chloromethylfluorescein diacetate, Molecular 
Probes) and incubated at 37°C for 20 min.  Cells were then spun down and 
resuspended in RMPI 1640 medium containing 10% FBS.  After the endothelial 
cells were sheared for the required times, the pre-labeled THP-1 cells were 
added onto the monolayers of endothelial cells and incubated at 37°C for 15 min.  
The unbound cells were rinsed off with PBS and the bound cells fixed with 2% 
formaldehyde.  To quantify the assays, five random fields under the 10X/0.30 
objective on a Leica DMIRB inverted microscope were counted for each assay 
and representative images were acquired using a QImaging RETIGA 1300 
camera. 
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Animals 
 
Shc-flox mice were a kind gift from Dr. Kodi Ravichandran at University of 
Virginia25.  Tie2-Cre (B6.Cg-Tg(Tek-cre)12Flv/J) mice were purchased from 
Jackson Labs.  All housing, breeding and experimental procedures using mice 
were in accordance with national guidelines and regulations and were approved 
by the Institutional Animal Care and Use Committee at the University of North 
Carolina- Chapel Hill.  Male Shc flox/flox; Tie2-Cre and age-matched littermates 
(Shc flox/flox, 10-14 weeks) were used for all experiments. To genotype animals, 
DNA was isolated from ears at weaning and PCR performed. All analyses were 
conducted by observers blinded to animal genotype. 
 
Unilateral Hindlimb Ischemia  
The surgery procedure was performed on the right hind limb as described 
previously14.  Briefly, animals were anesthetized with 1.125% isoflurane 
supplemented with oxygen, and body temperature was maintained at 37°C. Hair 
was removed from the hindquarters with a depilating cream. The femoral artery 
was exposed aseptically through a 2mm incision and isolated from vein and 
nerve. The femoral artery was ligated with 7-0 ligatures proximal to the 
bifurcation of the popliteal artery and distal to the lateral caudal femoral artery 
(LCFA) for the less severe ischemia mode. The incision was closed after the 
wound was irrigated with sterile saline. 
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 Laser-Doppler Imaging  
The animals were placed for 5min at a 37°C chamber before the measurements 
to avoid vasoconstriction by anesthetic heat loss. A Laser Doppler imager was 
used to estimate relative blood flow. Ratios of occluded over non-occluded 
values were compared. Noninvasive measurements of superficial hindlimb 
perfusion were obtained before ligation, immediately after ligation (acute), 7 and 
21 days after ligation 5. Plantar perfusion was quantified within anatomically 
defined regions of interest (ROIs). All ROIs were drawn by an investigator blind 
to animal genotype. Data are reported as perfusion ratios of ligated vs. sham 
control side. 
 
Morphometry  
Collateral arteries were harvested from mice as described previously14.  Briefly, 
animals were transcardially perfused at 100 mmHg with PBS containing 10 
nmol/l sodium nitroprusside and 10U/ml heparin 3 weeks after hindlimb ischemia. 
PBS was followed by 2% PFA for 20 min. We harvested the anterior and 
posterior gracilis muscles which contain three pre-existing collaterals. The 
midzone of the muscles (i.e., the 5-mm-wide centermost section) was trimmed. A 
section of the calf (gastrocnemius/soleus) muscle was also harvested for the 
examination of capillary density (described below).  Samples were embedded in 
paraffin and 5μm thick cross sections were H. & E. stained.  Lumen diameter of 
collateral arteries was measured as previously described14.  H&E stained cross-
sections within 0.5mm from the midzone of the collateral arteries in anterior and 
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 posterior gracilis muscles were digitized at 60x magnification.  Lumen 
circumference was measured interactively using NIH Image J package.  For each 
mouse, four arteries were studied, two from the surgery-operated side and two 
from the sham control side.  At least 4 cross-sections from each mouse were 
measured and the average lumen diameter of collateral vessel was used.  
 
Immunohistochemistry  
We used antibodies to NF−κB (1:200, BD Pharmingen, San Diego, CA), VCAM-1 
(1:200, Santa Cruz), CD45 (1:100, BD Pharmingen), PCNA (1:1000, Abcam, 
Cambridge, MA), ephrinB2 (1:200, R & D systems, Minneapolis, MN), Cleaved 
Notch-1 (1:100, Abcam), Phospho-Shc (1:100, BD Transduction) and Smooth 
Muscle α-Actin(SMC α-actin, 1: 1000, Sigma-Aldrich). Antigen retrieval was 
performed for cross sections with Retrogen (BD Pharmingen), except for NFκB 
and PCNA antibodies. Thyramide signal amplification (TSA, Perkins Elmar Inc, 
Waltham, MA) was performed for NFκB, VCAM-1, CD45, ephrinB2 and Cleaved 
Notch-1 staining, per manufacturer’s instruction. Primary antibody was incubated 
at 4oC overnight, followed by 60 minutes for biotinylated secondary antibody 
(1:500), and 30 minutes for ABC complex (Elite ABC kit, Vector Laboratories, 
Burlingame, CA). Cy3-thyamide was used to visualize the peroxidase-binding 
sites. To visualize collateral media, the slides were further incubated with mouse 
anti-SMC α-actin for 2 hours, followed by the incubation of Cy5-goat anti-mouse 
Ig G (1:100) for one hour. The slides were counter stained with DAPI to visualize 
cellular nuclei. 
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Leukocyte Density  
Leukocytes in the adventitia and periadventitia of pre-existing collaterals were 
detected with CD45 antibody as described above. CD45-positive cells having a 
blue nucleus surrounded by Cy3 fluorescence (from Cy3-thyramide) on their 
surface were counted by an observer blinded to the identity of the randomly 
arranged slides. Average leukocyte density was determined from 4 sections from 
each animal. 
 
Capillary Density  
Capillary density was counted as described previously14. Briefly, muscle fibers 
were harvested from the right and left side, from the m. adductor and m. 
gastrocnemius. The plasma membrane of capillary ECs in tissue sections was 
labeled with Alexa 568-IsolectinB4 (Invitrogen, CA). Micrographs were obtained 
with the Nikon fluorescence microscope using a 20x objective lens. Digitized 
images were analyzed with an image analysis package, Image J. The total 
number of capillaries was counted on 5 random optical fields for each mouse. 
Results are expressed in capillaries per muscle fiber. 
 
iMLEC Cell Culture & Shear Stress  
Shc flox/flox and Shc flox/flox; Tie2-Cre MLECs (for isolation protocol see26) were 
subjected to shear stress in vitro using a previously described cone and plate 
viscometer27.  100-mm tissue culture dishes were coated in 10g/ml Fibronectin, 
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 then MLECs were seeded and grown to confluence in EGM-2 (Lonza) with 10% 
FBS.  Then, MLECs were serum starved overnight in M-199 (Gibco) with 0.5% 
FBS and exposed to an arterial level of unidirectional laminar shear stress (15 
dyn/cm2) in the starvation medium for 4 hours or kept static as controls.  For 
inhibitor experiments, ECs were pre-treated for 1 hr with 20μM DAPT (Selleck 
Chem) or DMSO vehicle control in starvation media, then exposed to shear for 4 
hrs in the presence of inhibitor.  Immediately after treatment, dishes were 
washed 1x in cold PBS and frozen.  MLECs were lysed in TriZol for subsequent 
RNA isolation.   
 
Real-Time Quantitative PCR  
Total RNA was extracted from MLECs using Trizol reagent (Invitrogen, Inc, 
Carlsbad, CA) following manufacturer’s protocol. Total RNA (5μg) was reverse-
transcribed into cDNA with random primers and SuperScript II (Invitrogen) per 
manufacturer’s instruction. The primer pairs were as following (“-F”: forward, “-R”: 
reverse): GAPDH-F: 5’-GGC ATT GCT CTC AAT GAC AA -3’; GAPDH-R: 5’-
TGT TGC TGT AGC CGT ATT CA -3’; ephrinB2-F: 5’-GCG GGA TCC AGG AGA 
TCC CCA CTT GGA CT -3’; ephrinB2-R: 5’- GTG CGC AAC CTT CTC CTA AG -
3’; HES-F: 5’- TCC TTG GTC CTG GAA TAG TGC TA -3’; HES-R: 5’- ACT GAG 
CAG TTG AAG GTT TAT TAT GTC T -3’; Deltex-F: 5’- CAC TGG CCC TGT 
CCA CCC AGC CTT GGC AGG -3’; Deltex-R: 5’- GGG AAG GCG GGC AAC 
TCA GGC CTC AGG -3’.  SYBR Green I based real-time PCR (Absolute SYBR 
Green ROX Mix, Thermo Fisher Scientific, Surrey, UK) was performed in a Rotor 
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 Gene thermal cycler (Qiagen, Foster City, CA) with the following thermal 
parameters: 95°C 15 min, followed by 40 cycles of 95°C for 30sec, 57°C for 
30sec, 72°C for 30sec. Data were analyzed using relative real-time PCR 
quantification based on the ∆∆Ct method. GAPDH was the endogenous 
reference gene for ephrinB2, HES and Deltex, and the control was Shc flox/flox 
static MLECs. 
 
Statistical Analysis  
Values are presented as means ± SE. Differences was determined by Student t-
test (between two groups) and one-way ANOVA (among multiple groups). A 
value of P<0.05 was considered to indicate statistical significance.   
 
RESULTS 
Shc is Activated by Shear Stress 
Shc signaling function is regulated by three tyrosine residues (Y239, Y240 
and Y317) that are phosphorylated when Shc is activated.  To test whether Shc 
can be activated by shear stress, we subjected ECs to different flow patterns in 
vitro and assayed Shc activation using a phospho-Shc specific antibody.  ECs 
stimulated with prolonged disturbed flow (which is pro-inflammatory and 
atherogenic) showed elevated Shc phosphorylation compared to static ECs 
whereas ECs stimulated with extended laminar flow (which is considered anti-
inflammatory and atheroprotective) showed decreased Shc phosphorylation 
compared to static ECs (Figure 3.1A).  This indicates that Shc is activated by 
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 atherogenic disturbed shear but is preferentially de-activated by laminar 
atheroprotective shear.  Acute onset of laminar shear stimulates many of the 
same responses as chronic disturbed flow28; thus, a large number of in vitro 
studies have exploited the acute onset of laminar shear to model atheroprone 
signaling and obtain a temporal map of signaling cascades activated by shear 
stress7.  We therefore used the onset of laminar flow protocol to assay the early 
responses downstream of Shc.  In ECs, Shc phosphorylation was detected upon 
the onset of flow, as assessed by immunoblotting the cell lysates with a phospho-
Shc Tyr239/240 antibody (Figure 3.1B).  Notably, all three isoforms of Shc are 
phosphorylated in response to flow. Immunofluorescence staining showed that a 
fraction of activated Shc localized to cell-cell junctions (Figure 3.1C).  Flow-
induced phosphorylation of Shc Tyr317 was not observed in parallel experiments 
(data not shown), suggesting that the downstream signaling elicited by Shc in 
response to flow is primarily mediated through its phosphorylation at Tyr 
239/240. 
 
Shc Associates with Components of the ‘Mechanosensory Complex’ in 
Response to Shear Stress 
The distinct spatial activation of Shc in response to the onset of flow 
suggested that Shc might associate with components of endothelial cell-cell 
junctions. Recently, our lab identified a minimal complex necessary for a subset 
of EC shear stress responses, which requires PECAM-1, VE-cadherin and 
VEGFR-212.  To further investigate the role of Shc in shear stress signaling, the 
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 association of Shc with crucial components of the VE-cadherin−VEGFR-2 
signaling pathway was examined.  Onset of flow induced an acute association of 
Shc with VE-cadherin and VEGFR-2 (Figure 3.2A), suggesting the existence of a 
multi-protein complex induced by shear.  Importantly, the association of Shc with 
VE-cadherin was sustained under long term disturbed flow (Figure 3.2B), similar 
to the sustained Shc phosphorylation. 
 
Shear Stress Induced Shc Association with Integrin αvβ3 is Dependent on 
ECM Composition 
Binding of integrins to their specific ligand in the ECM induces integrin 
activation and intracellular recruitment of signaling adaptor proteins to the 
integrin29.  Shc has been shown to associate with activated integrin αvβ3 when 
the integrin is bound to its ligand, fibronectin (FN) or vitronectin (VN)20.  
Consistent with previous reports, shear stress induced Shc-integrin association in 
cells plated on FN and VN (both engage integrin αvβ3) but was absent in cells 
plated on collagen (CL) or laminin (LN) (both engage integrin α2β1) (Figure 3.2C).  
Importantly, the composition of the subendothelial ECM modulates inflammatory 
signaling and permeability in response to shear stress28, 30.  Orr et al. reported 
that the inflammatory transcription factor NF-κB is activated by shear stress only 
when ECs are growing on FN whereas shear stress does not activate NF-κB on 
CL28.  To determine whether Shc activation is also matrix specific, ECs were 
plated on either FN or CL and Shc phosphorylation was assayed.  Onset of flow 
triggered an increase in Shc phosphorylation irrespective of the matrix that the 
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 cells were plated on (Figure 3.2D), indicating that Shc phosphorylation is not 
ECM specific. To test whether the flow-induced Shc association with cell-cell 
junctions is ECM dependent, immunoprecipitation assays were performed with 
lysates from cells plated on FN or CL.  As shown in Figure 3.2E, Shc interaction 
with VE-cadherin was rapidly enhanced after the onset of flow regardless of the 
ECM composition.  Thus, Shc activation and association with cell-cell junctions 
correlate closely and occur independently of the matrix composition, whereas the 
later Shc-integrin association is ECM-dependent. 
 
Shc Mediates the Flow-Induced Inflammatory Response 
Shear stress regulates the chronic inflammation associated with 
atherosclerotic plaque formation31-33.  The Shc phosphorylation observed in 
response to atherogenic disturbed flow raises the possibility that Shc may 
participate in the regulation of the inflammatory response elicited by shear stress.  
NF-κB is a key regulator of shear stress-induced inflammatory gene expression 
and contributes to the initiation of atherosclerosis by shear stress.  In 
unstimulated cells, NF-κB is held inactive in the cytoplasm through its interaction 
with IκB.  Degradation of IκB results in NF-κB activation, nuclear targeting and 
initiation of transcription 34.  To test whether Shc is involved in flow-induced NF-
κB activation, we suppressed cellular levels of Shc using small interfering RNAs 
(siRNAs) (Figure 3.3A).  Knockdown of Shc expression prevented nuclear 
translocation of NF-κB by shear whereas control siRNA had no effect, suggesting 
that Shc is upstream of NF-κB activation in response to flow (Figure 3.3B).  
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 Nuclear NF-κB binds to a shear stress responsive element found in the 
promoter of several atherogenic genes, including ICAM-1 and VCAM-1, which 
regulate monocyte recruitment to the endothelium 35, 36.  To test whether the role 
of Shc in NF-κB activation by shear stress is functionally relevant for the shear-
induced inflammatory response, we tested whether Shc is required for shear 
stress-induced monocyte adhesion to the EC monolayer.  Interestingly, in control 
siRNA transfected cells, disturbed flow increased monocyte adhesion to the 
endothelium whereas it had no effect on monocyte adhesion to Shc siRNA 
transfected ECs (Figure 3.3C).  Thus, we conclude that Shc function is important 
for mediating the initial events in inflammation and atherogenesis induced by 
shear stress. 
 
Endothelial Shc is Required for Plantar Perfusion Recovery following 
Femoral Artery Ligation 
 To examine the role of endothelial Shc in shear stress-induced responses 
in vivo, conditional knockout Shc flox/flox; Tie2-Cre and control Shc flox/flox 
littermates (referred to as flox/flox and flox/flox; Cre, respectively) were subjected 
to hindlimb ischemia by ligation of the femoral artery, which triggers flow-induced 
adaptive remodeling of pre-existing collaterals from the deep femoral artery.  
Blood perfusion of hind paws (plantar) was non-invasively measured using Laser 
Doppler Imaging before surgery (pre), immediately after surgery (acute), and at 
various timepoints throughout the 3 week recovery period following surgery 
(Figure 3.4A). Plantar perfusion was quantified from the Doppler images and 
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 normalized to the sham control side of the same animal for the comparisons of 
different time points.  Strikingly, flox/flox; Cre mice displayed attenuated 
perfusion recovery as early as 3 days post-surgery (Figure 3.4B). The defect in 
perfusion recovery was exacerbated at each timepoint until the final timepoint 
showed a 40% reduction in plantar perfusion in flox/flox; Cre mice compared to 
flox/flox controls.  Importantly, in wild-type mice, femoral artery ligation induced 
rapid Shc phosphorylation in ECs that line pre-existing collateral arteries (Figure 
3.4C), indicating that endothelial Shc is activated in this model.  These data 
demonstrate that Shc is activated in ECs during collateral remodeling and that 
Shc is required for perfusion recovery following hindlimb ischemia. 
 
Shc is Required for Collateral Artery Remodeling & Angiogenesis 
 Plantar perfusion recovery following femoral artery ligation requires two 
EC-dependent vascular processes: arteriogenesis and angiogenesis5, 37.  
Ligation of the femoral artery causes a sudden increase in blood flow and 
hemodynamic force through pre-existing collateral arteries in the gracilis 
muscles, causing flow-induced outward vascular remodeling (arteriogenesis), 
therefore allowing more blood to be carried by the collateral artery.  
Simultaneously, ischemia in tissues distal to the ligation, such as the 
gastrocnemius muscle, induces angiogenesis in order to increase vascular 
density and blood perfusion.  In order to test whether Shc is required for 
arteriogenesis and/or angiogenesis, we examined the gracilis and gastrocnemius 
muscles after 3 weeks after ligation (or sham) surgery.  While there was no 
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 difference in basal gracilis collateral size in sham mice, we found that 3 weeks 
after ligation, the collaterals in flox/flox; Cre mice were ~30% smaller than those 
of control flox/flox littermates (Figure 3.5A).  Similarly, induction of angiogenesis 
in the ischemic gastrocnemius muscle was defective in flox/flox; Cre mice.  
Capillary density increased by almost 50% in control flox/flox, whereas flox/flox; 
Cre mice were refractory to induction of angiogenesis (Figure 3.5B). As 
arteriogenesis is the largest contributor to perfusion recovery38 we focused our 
attention on the role of Shc in collateral growth. 
 
Shc is Required for Flow-Induced NF-κB Activation & Inflammation in 
Collaterals 
 The attenuated plantar perfusion recovery and collateral remodeling in 
flox/flox; Cre mice suggests a role for Shc in arteriogenesis.  Sharp increases in 
hemodynamic forces in the collateral induces EC proliferation and inflammation; 
two EC-dependent processes that underlie arteriogenesis.  We assayed EC 
proliferation in collaterals of flox/flox; Cre and flox/flox mice by nuclear PCNA 
staining.  EC proliferation in collaterals 3 days after surgery was decreased in 
flox/flox; Cre mice compared to flox/flox controls (Figure 3.6A).  Similarly, we 
assayed the role of Shc in activation of inflammation in response to femoral 
artery ligation.  Collaterals were stained for infiltration of CD45-positive 
leukocytes, an important mediator of collateral remodeling.  flox/flox; Cre mice 
exhibited a significant decrease in CD45- positive leukocyte infiltration compared 
to flox/flox controls (Figure 3.6B), indicating a role for Shc in inflammation in 
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 response to hindlimb ischemia.  CD45-positive cell recruitment following femoral 
artery ligation requires activation of NF-κB in ECs52, so we tested the role of Shc 
in NF-κB activation in this model. While control flox/flox mice showed activation 
of NF-κB as early as 24hrs after ligation, flox/flox; Cre mice displayed defects in 
NF-κB activation (Figure 3.6C).  Interestingly, we also observed upregulation of 
p65 expression in ECs in flox/flox mice that was absent in flox/flox; Cre mice.  
This defect in p65 nuclear localization coincided with a decrease in expression of 
the NF-κB-dependent adhesion molecule Vascular Cell Adhesion Molecule-1 
(VCAM-1) (Figure 3.6D).  Together, these data indicate that Shc is required for 
EC proliferation and inflammation during collateral remodeling, both of which are 
critical for recovery from hindlimb ischemia. 
 
Notch-Dependent Collateral EC Arterial Specification Requires Shc 
 The EC phenotype is plastic and heterogeneous throughout the vascular 
tree, and the expression of arterial- and venous-specific genes is the 
consequence of local hemodynamic cues that may regulate vessel remodeling 39, 
40.  Because ECs in collaterals quickly change from a low flow environment to a 
high shear stress environment following femoral artery ligation41, 42, we 
hypothesized that collateral ECs adopt a more ‘arterial identity’ to suit the new 
arterial-like blood flow environment.  To test this, we stained collateral tissue 
sections for a marker of arterial (as opposed to venous) ECs, ephrinB2 43.  
EphrinB2 expression was upregulated in flox/flox collateral ECs 3 days after 
ligation, however, ephrinB2 upregulation was absent in flox/flox; Cre mice, 
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 indicating that Shc is required for arterial specification of ECs in response to 
changes in the hemodynamic environment in collaterals (Figure 3.7A).  Because 
ephrinB2 is transcriptionally regulated by the Notch transcription factor NICD 44, 
we next examined activation of Notch in collaterals.  In control flox/flox mice, 
femoral artery ligation induced Notch activation (NICD nuclear localization) in 
collateral ECs, whereas Notch activation was impaired in flox/flox; Cre mice 
(Figure 3.7B).  These data indicate that Shc is important for activation of the 
Notch pathway and arterial specification of the remodeling collateral arterioles. 
ECs in collateral arteries experience several mechanical and chemical 
stimuli simultaneously during arteriogenesis, making it difficult to delineate the 
exact role of Shc during collateral remodeling. We therefore tested the role of 
Shc in shear stress-induced Notch activation and ephrinB2 upregulation using an 
in vitro system.  Onset of shear stress induced expression of the Notch target 
genes ephrinB2, HES and Deltex in ECs isolated from flox/flox mice. In contrast, 
shear-induced upregulation of Notch target genes was impaired in the absence 
of Shc (Figure 3.7C).  Shear-induced gene regulation is dependent on Notch, as 
wild-type cells treated with the γ-secretase inhibitor DAPT failed to activate any of 
the Notch target genes (data not shown).  Together, our data show that Shc is 
required for shear stress-induced arterial specification by mediating Notch-
dependent ephrinB2 upregulation in ECs. 
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 DISCUSSION 
 In this Chapter, I present evidence that Shc is required for shear stress-
induced signaling in ECs both in vitro and in the mouse.  Shc is phosphorylated 
in response to acute onset of shear stress and associates with components of 
the junctional mechanosensory complex VE-cadherin and VEGFR-2 at early 
times after the onset of flow; and with integrin-ECM adhesions at later times.  
While Shc phosphorylation and its association with VE-cadherin are ECM-
independent, Shc binding to integrins occurs only on FN and not on CL.  
Depletion of Shc in ECs impairs flow-induced inflammation, including NF-κB 
activation and leukocyte adhesion to the endothelium.  Interestingly, the 
activation of NF-κB signaling is ECM specific and correlates with the ECM 
specificity for the Shc-integrin association.  In the mouse, Shc is also required for 
response to shear stress, as flox/flox; Cre mice displayed a marked reduction in 
restoration of blood flow to distal tissue following femoral artery ligation.  Onset of 
flow after ligation induced Shc phosphorylation in ECs of collateral arteries.  
Histological analyses revealed defects in angiogenesis in the microvasculature in 
the ischemic tissue, as well as defects in arteriogenesis due to impaired pre-
existing collateral remodeling.  Mechanistically, Shc mediates vessel 
inflammation and activation of the transcription factor NF-κB as well as 
proliferation, both of which are critical for arteriogenesis.  Unexpectedly, Shc is 
also required for arterial specification of the remodeling collateral arterioles by 
mediating shear-induced Notch activation and expression of the arterial EC 
marker ephrinB2. 
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  The contribution of Shc to both integrin- and growth factor- signaling is 
well documented17, 20, 21, but this is the first report to reveal a role for Shc in 
inflammatory signaling through NF-κB.  It has recently been shown that flow-
induced NF-κB activation is ECM-dependent and is only observed in cells plated 
on FN, but not on CL28.  In addition, we have shown that the association of Shc 
with integrins in response to flow is ECM-specific.  Interestingly, FN deposition is 
increased in atheroprone vessels that experience disturbed flow28 as well as in 
collateral vessels in animals subjected to femoral artery ligation 45.  Taken 
collectively, these data suggest a pathway in which FN deposition is upregulated 
in vessels during atherogenesis and arteriogenesis, which enhances shear 
stress-induced Shc signaling and leads to inflammation.  In curved or branched 
arteries, disturbed flow is constitutive, leading to a chronic inflammatory response 
that is pathological whereas in collateral vessels, the increased shear stress is 
transient leading to a transient inflammatory response that is physiological and 
beneficial to the animal.  Transient Shc phosphorylation occurs in response to 
acute onset of laminar flow in vitro and in collaterals following femoral artery 
occlusion in vivo and this Shc phosphorylation activates transient inflammation 
that drives physiological remodeling of the collateral arteries.  However, 
sustained Shc phosphorylation occurs in atheroprone curved or branched 
vessels leading to chronic inflammation that causes plaque formation.  Therefore, 
Shc regulates the switch between chronic, pathological inflammation associated 
with atherosclerosis and transient, beneficial inflammation associated with 
arteriogenesis.   
   83  
 The Notch pathway is critical for embryogenesis 46 and development of the 
cardiovascular system47, 48, but its role in adult physiology is less well-defined.  
Mice heterozygous for Notch-1 or the Notch ligand Dll-1 exhibit reduced plantar 
perfusion recovery following femoral artery ligation, similar to the phenotype 
observed in Shc flox/flox; Tie2-Cre mice49, 50.  These studies suggested that the 
Notch pathway is activated downstream of VEGF, which is produced by ischemic 
tissue and drives angiogenesis.  Here, we introduce an alternative model in 
which shear stress directly activates the Notch pathway and results in 
upregulation of Notch target genes such as ephrinB2 in remodeling collateral 
arteries.  We show that activation of the Notch pathway by shear stress requires 
Shc, which mediates signal transduction downstream of the mechanosensory 
complex of PECAM-1, VE-Cadherin and VEGFR-2.  Shear-stress induced 
activation of the Notch pathway facilitates arterial specification of collateral ECs 
as they remodel into high-flow carrying arterioles.  The mechanism to explain 
how Notch is activated by shear stress is currently not well understood, although 
two hypotheses exist.  One possibility is that shear stress induces expression of 
a Notch ligand which in turn activates Notch in trans through the canonical 
pathway.  A second possibility is ligand-independent Notch activation in which 
intracellular signals activate γ-secretase, which in turn cleaves Notch.  Similarly, it 
remains unclear whether arterial-specification of ECs in remodeling arterioles is 
required for, or is merely a consequence of, the remodeling process.  EC-specific 
knockout of the arterial EC marker ephrinB2 is embryonic lethal 51, precluding 
any experiments to address this question in the adult mouse.   
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 Figure 3.1: Shc is activated by shear stress 
 
(A) BAECs were plated on FN-coated slides and subjected to disturbed or 
laminar flow for 18 hrs or kept as static controls.  Whole cell lysates were 
analyzed by immunoblotting with anti-Shc phospho-Tyr239/240 or anti-Shc 
antibodies.  (B) BAECs were plated on FN-coated slides and sheared for 1, 5, 30 
min or kept as static controls.  Cell lysates were subjected to SDS-PAGE and 
immunoblotting with anti-Shc phospho-Tyr239/240 or anti-Shc antibodies.  (C) 
BAECs were subjected to laminar flow at 12 dyne/cm2 for 5 min or kept static as 
control.  Cells were subsequently fixed, permeabilized and immunostained for 
phospho-Tyr239/240 of Shc.   
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 Figure 3.2:  Shear stress induces ECM-independant Shc association with 
the ‘mechanosensory complex’ & ECM-dependant Shc association with 
integrins 
 
(A)  BAECs were plated on FN-coated slides and subjected to laminar flow at 12 
dyne/cm2 for 5 min or kept static as control.  Cells were lysed and Shc protein 
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 was immunoprecipitated from whole cell lysates using anti-Total Shc antibody.  
Immunoprecipitated proteins were separated using SDS-PAGE and 
immunoblotted for Shc, VEGFR-2 and VE-Cadherin.  (B)  BAECs grown on FN-
coated slides were kept static or subjected to laminar or disturbed shear stress 
for 18 hrs.  Cells were lysed and Shc protein was immunoprecipitated from whole 
cell lysates using anti-Total Shc antibody.  Immunoprecipitated proteins were 
separated using SDS-PAGE and immunoblotted for Shc and VE-Cadherin.  (C)  
Slides were coated with vitronectin (VN), collagen (CL), laminin (LM) or 
fibronectin (FN).  BAECs were sheared for 30 min or kept as static controls.  Cell 
lysates were immunoprecipitated with LM609 anti-αvβ3 followed by 
immunoblotting with anti-Shc antibody.  (D) BAECs were plated on CL- or FN-
coated slides and sheared for 5, 30 min or kept as static controls.  Cell lysates 
were subjected to SDS-PAGE and immunoblotted with anti-Shc phospho-
Tyr239/240 or anti-Shc antibodies.  (E) BAECs were plated on CL- or FN-coated 
slides and sheared for 1, 5 min or kept as static controls.  Cell lysates were 
immunoprecipitated with a VE-cadherin specific antibody and immunoblotted with 
anti-Shc or anti-VE-cadherin. 
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 Figure 3.3:  Shc is required for shear stress-induced NF-κB activation & 
leukocyte adhesion to the endothelium 
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 (A) BAECs were transfected with control siRNA or ShcA siRNA as described in 
the Materials and Methods.  Cells were lysed at indicated times after transfection 
and cell lysates analyzed by immunoblotting with Shc specific antibody to confirm 
the knockdown effect of the Shc siRNA.  Blots were stripped and reprobed with 
an antibody against Actin as a loading control.  (B) BAECs were transfected with 
control siRNA or Shc-specific siRNA.  48 hours after transfection, cells were 
exposed to disturbed flow for 30 min or left as static control.  Cells were fixed, 
permeabilized and stained for the p65 subunit of NFκB as described in the 
Materials and Methods.  Three independent experiments were performed and 
100 cells were counted for each experiment (**, p < 0.01).  (C) BAECs were 
transfected with control siRNA or Shc-specific siRNA.  48 hours after 
transfection, cells were exposed to oscillatory flow for 8 h or left as static control.  
THP-1 monocytes pre-labeled with CellTrackerTM Green were added to BAECs 
monolayers and monocyte binding assay was performed as described in the 
Materials and Methods. Bar, 100μm. (Right) Quantitation of monocyte binding 
represented as mean ± S.D. for three independent experiments (∗, p < 0.05).  
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 Figure 3.4:  Shc signaling regulates plantar perfusion recovery following 
hindlimb ischemia 
 
(A)  Defective perfusion recovery following femoral artery ligation in conditional 
knockout Shc flox/flox; Tie2-Cre mice compared to Shc flox/flox control 
littermates.  Representative LDI scans of plantar perfusion before (Pre), 
immediately after (Acute), 7 days (7d), and 3 weeks after hindlimb ischemia 
surgery. Pseudocolor scale (in arbitrary units): black indicates 0; white, 1000. (B)  
Ratio of plantar perfusion (ligated vs sham control side) quantified from the LDI 
images. Values are provided as mean +/- SEM. *= p<0.05, compared with the 
respective time point of Shc flox/flox controls.  n= 9 flox/flox and 10 flox/flox; 
Tie2-Cre per timepoint.  (C)  Cross-section staining of a pre-existing collateral 
artery 24 hrs after ligation (or sham control).  Slides were stained with phospho-
Shc Y239, 240 (red), Smooth Muscle α-actin (green) and DAPI (blue).  
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 Figure 3.5:  Shc is required for pre-existing collateral remodeling & 
angiogenesis 
 
(A)  Collateral lumen area in sham and ligated hindlimbs 3 weeks after femoral 
artery ligation surgery in Shc flox/flox and Shc flox/flox; Tie2-Cre mice. Cross-
sections of the gracilis muscle were H&E stained and collateral lumen area was 
measured.  Values are provided as mean +/- SEM. *= p<0.05.  (B)  Angiogenesis 
response was measured in sham and ligated hindlimbs 3 weeks after femoral 
artery ligation surgery in Shc flox/flox and Shc flox/flox; Tie2-Cre mice.  
Gastrocnemius muscle was cross-sectioned and stained with TRITC-Wheat 
Germ Agglutinin.  Capillary density was quantified as number of capillaries per 
muscle fiber in 5 random fields per mouse.  Values are provided as mean +/- 
SEM. *= p<0.05.  n= 8 flox/flox and 8 flox/flox; Tie2-Cre for both (A) and (B).   
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 Figure 3.6:  Shc is required for collateral EC proliferation & inflammation 
 
Proliferation and inflammation in the vessel wall was assessed by analyzing 
cross-sections of collateral arteries 3 days after femoral after ligation (or sham) 
surgery.  (A)  Sections were stained with PCNA to mark proliferating cells (red), 
Smooth Muscle α-actin (green) and DAPI (blue).  Quantitation (right) is shown as 
% PCNA positive ECs.  (B) Quantitation of CD-45 positive-cell accumulation in 
the vessel wall 3 days after surgery.  (C)  Staining of collaterals for NF-κB 
subunit p65 (red), Smooth Muscle α-actin (green) and DAPI (blue).  Quantitation 
(right) displayed as % ECs with nuclear (active) p65 localization.  (D)  Staining of 
collaterals for Vascular Cell Adhesion Molecule (VCAM) (red), Smooth Muscle α-
actin (green) and DAPI (blue).  Scale bars = 20μm.  For all quantitation, values 
are provided as mean +/- SEM. *= p<0.05.  n= 8 flox/flox and 8 flox/flox; Tie2-Cre
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 Figure 3.7:  Shc regulates shear stress-induced collateral EC arterial 
specification via activation of the Notch pathway 
 
(A)  Upregulation of arterial EC marker ephrinB2 during collateral arteriogenesis 
requires Shc.  Staining of collaterals 3 days after femoral ligation (or sham) 
surgery for ephrinB2 (red), Smooth Muscle α-actin (green) and DAPI (blue).  (B)  
Activation of Notch transcription factor requires Shc.  Staining of collaterals for 
Cleaved Notch-1 (red), Smooth Muscle α-actin (green) and DAPI (blue).  
Quantitation (right) displayed as % ECs with active Cleaved Notch-1.  N= 8 
flox/flox and 8 flox/flox;Cre.  (C)  Shc is required for shear stress-induced Notch-
target gene activation.  Relative mRNA expression of Notch target genes ephrin-
B2, HES and Deltex in ECs from flox/flox vs. flox/flox; Tie2-Cre mice.  ECs were 
sheared for 4 hrs at 15 dynes/cm2 or kept static as a control.  Values are shown 
as mean +/- SEM (n=4 independent experiments).   *= p<0.05.   
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CHAPTER IV. 
 
CONCLUSIONS & PERSPECTIVES 
 
OVERVIEW OF FINDINGS 
 This dissertation identifies the adaptor protein Shc as an important 
regulator of signaling in ECs.  Before this work, Shc was underappreciated as a 
signaling molecule in ECs, known mostly for its adaptor function in mediating 
signaling pathways downstream of receptors for EGF 1, PDGF 2, 3, Insulin 4-7 and 
bFGF 8, 9 in non-endothelial cells, usually leading to activation of Ras and 
mitogenic signaling through the MAPK pathway.  The generation of the Shc 
knockout mouse revealed a role for Shc in the developing cardiovascular system; 
however, the embryonic lethality of the global knockout was not conducive to 
studies on the role of Shc in adult physiology and pathology. This dissertation 
has outlined an important role for Shc in regulating the EC-specific signaling 
pathways activated by VEGF and shear stress (Figure 4.1).  Additionally, we are 
the first to implicate Shc in the NF-κB and Notch pathways which are required for 
vessel inflammation and arterial specification, respectively.  While Chapters II 
and III of this dissertation can be seen as a standalone stories, the findings fit 
together to form a cohesive picture of Shc signaling in ECs downstream of 
VEGFR-2 and integrin stimulation.  The stimulus that activates Shc signaling 
  
 defines the EC response, but key players in these distinct responses are 
conserved: VEGFR-2, integrins αvβ3 and/or α5β1 and Shc.  This Chapter briefly 
highlights the key findings from Chapters 2 and 3, explains the significance of the 
research in terms of the vascular biology field, and proposes future research 
which may prove beneficial in expanding the understanding of Shc signaling in 
vascular biology and in the context of human disease. 
 
CHAPTER II:  THE ADAPTOR PROTEIN SHC INTEGRATES GROWTH 
FACTOR AND ECM SIGNALING DURING POSTNATAL ANGIOGENESIS 
 Angiogenesis, the growth of new blood vessels as they sprout from pre-
existing vasculature, has been an active area of research since Dr. Judah 
Folkman hypothesized that tumor growth could be limited by inhibiting 
angiogenesis in the early 1970s.  This idea persists more than 40 years later, as 
several angiogenesis inhibitors are currently in use or in clinical trials.  The 
results of the angiogenesis inhibitors currently in use have largely been 
disappointing, underlying the need for further understanding of the angiogenic 
process.   
 Since Dr. Folkman’s seminal papers, a wealth of research has uncovered 
a great deal about how angiogenesis is activated and regulated 10.  Soluble pro-
angiogenic growth factors are produced by hypoxic or tumor tissue and bind to 
receptors expressed on the surface of ECs, activating the previously quiescent 
EC layer.  The activated ECs then loosen cell-cell adherens junctions and 
express proteases that degrade the surrounding ECM to allow space for the 
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 activated ECs to sprout a new vessel off of the parent vessel.  The activated EC 
adopts a ‘tip cell’ fate, meaning the EC is highly motile and invades the 
underlying tissue, whereas the neighboring ECs adopt a ‘stalk cell’ fate, where 
the ECs maintain connections to the parent vessel, proliferate and lumenize the 
nascent sprout.  Several major signaling pathways are required to coordinate the 
many steps of the complex angiogenesis process.  VEGF is the major 
‘angiogenic factor’ whose receptor, VEGFR-2, is specifically expressed on ECs 
and induces proliferation (via the MAPK pathway), migration (via Rho small 
GTPases and p38 MAPK), survival (via the PI3K-Akt pathway) and degradation 
of the ECM (via MMPs) 11.  VEGF activity can be modulated by expression of the 
VEGF sink sFlt-1 by stalk cells which sets up a narrow VEGF gradient through 
which a sprout migrates 12, 13.  Integrins αvβ3 and α5β1 are upregulated in VEGF-
activated angiogenic ECs and blockade of these integrins has been shown to 
decrease angiogenesis by increasing apoptosis of ECs14.  Together, these 
pathways orchestrate the complex processes that encompass angiogenesis, and 
cross-talk between these major pathways is beginning to be uncovered.  For 
example, the Byzova lab has shown that integrin function is required for VEGFR-
2 activation in response to VEGF treatment of ECs, and VEGFR-2 binds integrin 
αvβ3 in response to its activation, indicating crosstalk between the two receptors 
is necessary for proper function15, 16.   
 My research has contributed to the field of angiogenesis in two ways.  
First, I have uncovered a novel function for the adaptor protein Shc in 
angiogenesis due to its role in mediating a subset of signaling from VEGFR-2 
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 and integrins.  These results are important to the angiogenesis field in that they 
further our understanding of the VEGF and integrin signaling pathways that are 
critical for angiogenesis.  While extensive research has reported that VEGF and 
integrin signaling are important for angiogenesis due to their roles in activating 
ERK MAPK, PI3K-Akt and other pathways17, surprisingly little was known about 
the proteins that transmit signals from these receptors at the cell surface into a 
functional response.  My research has shown that Shc is required for proper 
postnatal angiogenesis in several complementary models and the use of 
pertinent animals models combined with mechanistic studies in vitro provide a 
detailed story of how Shc requlates angiogenesis at the cellular and organismal 
levels.  Until my work, the study of Shc’s role in cardiovascular signaling was 
precluded by embryonic lethality of the global Shc knockout mouse18.  We 
circumvented this issue by conditionally removing Shc from ECs in the mouse 
using Tie2-Cre-LoxP genetics and found that EC-specific Shc knockout mice 
were born at normal Mendelian ratios, providing an important tool for the future 
study of Shc in cardiovascular physiology and pathology.  
 A second, more general contribution to the field of EC signaling and 
angiogenesis is the observation that Shc mediates cross-talk between VEGF-
Receptors and integrins.  The critical experiment, Figure 2.6, shows that VEGF-
induced EC survival requires Shc only when ECs are grown on FN, whereas ECs 
on CL do not require Shc for survival in response to VEGF.  This experiment 
indicates that VEGF-induced survival is integrin-dependent and because FN-
binding integrins such as αvβ3 and α5β1 recruit Shc whereas CL-binding integrins 
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 such as α2β1 do not, Shc mediates the crosstalk between VEGFR-2 and integrins 
when ECs are grown on FN.  This idea of crosstalk between multiple receptors 
via adaptor proteins is largely under-studied, but may become more prevalent as 
signaling pathways begin to be thought of as interconnected webs rather than 
linear, binary switches.  My research is one example of how an EC functional 
response depends on coordination of signals from two different receptors by a 
soluble cytoplasmic adaptor protein such as Shc. 
 Several further questions have arisen from the above data, and these will 
be the focus of future research.  One major question is mechanistically, how Shc 
is able to mediate crosstalk between VEGFR-2 and integrins.  Previous reports 
have shown that VEGF treatment of ECs induces physical association of 
VEGFR-2 with integrin αvβ315, so perhaps the simplest hypothesis is that Shc 
mediates the association between VEGFR-2 and integrin αvβ3.  However, a direct 
physical association of VEGFR-2 with integrin αvβ3 has recently been reported in 
a test tube in the absence of Shc45, indicating that Shc does not promote 
association of VEGFR-2 with integrin αvβ3.  An alternative hypothesis is that Shc 
mediates signaling from VEGFR-2 and integrin αvβ3 separately and integrates the 
signal from each of these receptors into one coordinated cellular response.  This 
hypothesis is supported by protein domain structure-function analysis that Shc 
binds VEGFR-2 via its SH2 domain after VEGF treatment19, whereas Shc binds 
integrin β3 using its PTB domain20.  This indicates that Shc protein has two 
distinct binding sites for VEGFR-2 and αvβ3 that Shc could use to bind each 
receptor in succession.  Because Shc uses different domains to bind each of 
   103  
 these receptors, an important future experiment will be to create mutant Shc 
constructs in which the SH2 and/or the PTB domains are mutated so they are 
unable to interact with VEGFR-2 or integrin β3.  We will transfect mutant Shc 
constructs that can only bind VEGFR-2 or integrin αvβ3 but not both into ECs and 
assay for angiogenesis readouts such as sprouting in Fibrin gel, association of 
VEGFR-2 with integrin αvβ3, haptotaxis on FN, cell survival and Akt activation by 
VEGF and adhesion to FN.  If SH2 and PTB domain-mutant ECs are unable to 
sprout in Fibrin gel, we will conclude that binding of Shc to both VEGFR-2 and 
integrin αvβ3 are required for signaling during angiogenesis.  Conversely, if one of 
the mutants is still able to form productive sprouts, we will conclude that 
association of Shc with only one receptor is sufficient for sprouting.  Similarly, if 
VEGF-induced signaling occurs normally in the Shc PTB-mutant cells, this would 
indicate that Shc mediates VEGFR-2 signaling independent of β3 binding.  
However, if no signaling occurred and the VEGFR-2:integrin β3 complex did not 
form, this would indicate that Shc binds both receptors simultaneously and brings 
together a ternary complex that is capable of signaling. 
 Another interesting question related to angiogenesis in general is why do 
Shc flox/flox; Tie2-Cre mice survive embryogenesis and develop into adulthood 
normally?  We know that angiogenesis is critical to embryonic development for 
expansion and remodeling of the vasculature and we also have shown that Shc 
is important for angiogenesis, so how do the Shc EC-specific knockout mice 
survive throughout development?  The answer to this question has been elusive, 
although three hypotheses exist.  First, conditional knockout mice could escape 
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 embryonic lethality if the Cre driver promoter is turned on after the critical stage 
of development.  This does not appear to be the case for the Shc flox/flox; Tie2-
Cre mice because several papers have reported that Tie2-Cre is turned on by 
E9.5 21 while global Shc knockout mice develop normally until E11.5 18.  Another 
possible explanation is that postnatal angiogenesis occurs by a different 
mechanism than embryonic angiogenesis.  Emerging research has set precedent 
for the idea that conditional gene knockout using the Tie2-Cre transgene can 
result in mice that initially develop a normal vasculature, while exhibiting 
defective angiogenic capacity.  Tie2-Cre mediated conditional knockout of genes 
such as Endothelin-122, 23, TFPI24, ADAM1725, PPARγ 26 and Dicer 27 yield viable 
mice with cardiovascular defects, while the corresponding global knockout animal 
is embryonic lethal.  Thus, embryonic angiogenesis may use different adaptor 
proteins in ECs to transmit signals, or the angiogenic microenvironment (growth 
factors, ECM, hypoxia conditions) may be different in the embryo than in the 
adult, activating slightly different signaling pathways that do not require Shc.  A 
third hypothesis to explain how Shc flox/flox; Tie2-Cre mice survive 
embryogenesis is compensation for loss of Shc by some other adaptor protein, 
which is able to perform enough of Shc’s function to permit development.  Shc 
mediates protein-protein interactions of signaling cascades through use of SH2 
and PTB phospho-tyrosine binding domains.  Approximately 115 SH2 domain 
containing proteins28and 24 PTB domain containing proteins29 are known in the 
human genome, so functional compensation by one or more of these proteins is 
possible, simply because of the high concentration of proteins with similar protein 
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 binding domains available in the cytoplasm.  ECs express SH2 and PTB-
containing adaptor proteins such as Focal Adhesion Kinase (FAK) and Src-
Family Kinases Src, Yes and Fyn which have been shown to bind integrin αvβ3, 
while Gab1 is another SH2-containing adaptor protein that has been shown to 
bind VEGFR-2.  More proteins similar in structure such as Grb2, Nck and Cbl 
exist in ECs and have been shown to mediate signaling downstream of RTKs.  
We have not yet explored the issue of compensation by other adaptors in Shc 
flox/flox; Tie2-Cre mice or ECs, but it is an interesting possibility to address in the 
future. 
 
CHAPTER III:  SHC MEDIATES THE ENDOTHELIAL RESPONSE TO SHEAR 
STRESS IN VITRO AND DURING ARTERIOGENESIS IN VIVO  
 Atherosclerosis, the buildup of cells, ECM and lipids in the vessel wall 
causing narrowing of the lumen and reduced perfusion of the downstream tissue 
is the leading cause of death in industrialized nations.  Atherosclerosis was 
initially thought to be caused by passive deposition of lipid in the vessel wall 
simply due to high concentrations of circulating low density lipoproteins.  
However, plaque formation occurs preferentially at sites of vessel curvature and 
bifurcation while high cholesterol is systemic, indicating some other atherogenic 
stimulus occurs at these discrete locations.  In 1973, Russell Ross proposed the 
“Response-to-Injury” hypothesis which states that endothelial injury induces 
chronic inflammation, which is the primary cause of atherosclerotic plaque 
formation 30.  Subsequent research has shown that shear stress, the frictional 
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 drag force of blood flowing over the endothelium, can cause endothelial injury 
and chronic inflammation that initiates atherogenesis 31.    
 Disturbed shear stress exists at athero-prone vessel curvatures and 
bifurcations, and activates a chronic inflammatory response in ECs of these 
vessels.  Shear stress can be sensed by a variety of different mechanoreceptors 
located at the EC luminal surface (primary cilia and ion channels), basal surface 
(integrins) and cell-cell adhesions31.  Tzima et al. reported a mechanosensory 
complex located at cell-cell junctions comprised of PECAM-1, VE-Cadherin and 
VEGFR-2 which is necessary and sufficient for the EC response to shear 
stress32.  Activation of the mechanosensory complex by shear stress induces 
several signaling cascades such as activation of Src-family kinases, MAPKs, and 
the inflammatory transcription factor NF-κB 32, 33.  These pathways activate the 
normally quiescent EC monolayer and induce EC proliferation, lipid uptake into 
the vessel wall, and chronic inflammation which promotes leukocyte 
transmigration into the underlying tissue.  Each of these events contributes to the 
growth of atherosclerotic plaques, and further understanding of the mechanism 
by which shear stress is sensed and responded to will aid in establishing targets 
for treatment and prevention of atherosclerosis.  PECAM-1, a component of the 
mechanosensory complex, is required for shear stress-induced inflammation and 
development of atherosclerotic plaques in regions of disturbed flow 34, 35 in 
hypercholesterolemic mice, further indicating that the response to disturbed 
shear is a driving force in atherogenesis.   
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  At the onset of my thesis research, a gap existed between the membrane 
bound mechanosensory complex and the major signaling nodes that were known 
to be activated by shear stress (such as NF-κB).  My research contributed to the 
shear stress/mechanotransduction field by identifying an adaptor protein, Shc, 
which is required for signaling directly downstream of the mechanosensory 
complex.  Shear stress induces a physical association of Shc with VE-Cadherin 
and VEGFR-2, two components of the mechanosensory complex, as well as Shc 
phosphorylation at Tyr239,240.  Importantly, Shc phosphorylation remained high 
even after 18 hrs of disturbed flow, whereas Shc was de-phosphorylated 
(compared to static cells) in response to 18 hrs of atheroprotective laminar flow.  
These results indicate that Shc is constitutively active in areas of disturbed flow 
and may contribute to chronic inflammation in these vessels.  Shc-depleted ECs 
showed impaired NF-κB activation and leukocyte adhesion in response to 
disturbed shear stress.  This was the first time that Shc was implicated upstream 
of NF-κB activation in any cell type.  These in vitro findings that Shc mediates 
shear-induced NF-κB activation and is constitutively activated in areas of 
disturbed flow potentially make Shc a critical player in shear-induced 
inflammatory signaling.   
 To confirm that Shc plays a major role in signaling in response to shear 
stress in vivo, Shc was conditionally knocked out of ECs and mice were 
subjected to femoral artery ligation surgery.   Femoral artery ligation reroutes 
blood from the femoral artery into pre-existing collateral arteries and this sudden 
increase in blood flow promotes vascular remodeling known as arteriogenesis.  
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 Arteriogenesis is driven by a sudden increase in hemodynamic force, which 
activates EC and SMC proliferation, NO production and vessel dilation, and 
inflammation which contribute to outward remodeling and widening of the 
collateral arteries to allow perfusion of the ischemic tissue36, 37.  We found that 
Shc expression in ECs is required for recovery of perfusion to the ischemic hind 
limb, and Shc flox/flox; Tie2-Cre mice exhibited defective arteriogenesis which 
may explain the decrease in recovery of foot perfusion.  Mechanistically, Shc 
flox/flox; Tie2-Cre mice were unable to increase EC proliferation or inflammation 
in response to femoral artery ligation; two processes that are important for vessel 
remodeling 38.  These results confirmed our in vitro data that Shc is required for 
NF-κB activation by shear stress and advanced these findings by showing that 
Shc is required for shear-induced inflammation and vessel remodeling in the 
mouse.   
 Vascular ECs are not the only cell type that is capable of responding to 
shear stress.  Epithelial cells lining tubes in the kidney 48 and in the airway 49 can 
sense fluid or air flow, smooth muscle cells in vessels in which ECs are denuded 
can respond to flow 47, and interstitial fluid flow in bone regulates differentiation 
and gene expression in osteoblasts 50.  Shc is ubiquitously expressed in the 
adult, so one wonders whether the role for Shc in the response to shear stress is 
conserved in these non-vascular cell types, or if Shc has a unique EC-specific 
function.  Based on the literature and what we know about mechanotransduction 
in ECs, it is likely that both of these possibilities are true.  Shc participates in 
shear-induced signaling from two important mechanosensors – the PECAM-
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 1:VE-Cadherin:VEGFR-2 ‘mechanosensory complex’ and integrins.  Expression 
of PECAM-1, VE-Cadherin and VEGFR-2 are restricted to ECs and therefore, the 
role of Shc in mechanotransduction from this complex is a unique EC-specific 
function of Shc.  However, integrins are expressed by several cell types and 
recently, Shc has been implicated downstream of integrins in shear-sensing in 
osteoblast-like cells 51, 52.  Therefore, Shc may have a ubiquitous function in 
mechanostransduction via integrins in cell types other than vascular ECs.   
 This research has contributed significantly to the fields of atherosclerosis 
and mechanotransduction by identifying the first adaptor protein that is required 
for shear stress-induced signal transduction downstream of the ‘mechanosensory 
complex.’  Shc is activated by atherogenic, disturbed shear stress and mediates 
vascular inflammation, which has been shown to be a primary cause of 
atherosclerotic plaque formation.  Therefore, it is likely that Shc is required for 
atherosclerotic plaque formation in areas of disturbed flow and future 
experiments will aim to examine this question directly.  Shc flox/flox; Tie2-Cre 
mice will be crossed to Apolipoprotein E null mice 39 to create 
hypercholesterolemic Shc flox/flox; Tie2-Cre; ApoE-/- mice that lack Shc in ECs.  
These mice and control Shc flox/flox; ApoE-/- mice will be fed a high fat diet to 
induce atherosclerotic plaque development and aortic plaque burden will be 
assessed by Oil Red O staining in areas of disturbed vs. laminar flow.  We 
hypothesize that Shc flox/flox; Tie2-Cre; ApoE-/- mice will have decreased 
atherosclerosis in areas of disturbed flow, such as the aortic arch due to reduced 
inflammation in the vessel wall, which we have shown is regulated through Shc.  
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 We expect less NF-κB activation and less leukocyte accumulation in the vessel 
wall of Shc flox/flox; Tie2-Cre; ApoE-/- mice in areas of disturbed flow due to the 
inability of these mice to respond to shear stress.  Combining the in vitro cell 
biology, the arteriogenesis data and the future atherosclerosis study, we will 
provide a comprehensive picture of how Shc is required for shear stress-induced 
vascular inflammation and atherosclerosis.  Because Shc is activated in areas of 
disturbed flow and mediates shear-induced inflammation, phospho-Shc may be a 
fruitful target for treating and preventing atherosclerosis.  However, in light of the 
results presented in Chapter 3, one important caveat for targeting phospho-Shc 
as a treatment for atherosclerosis may be the undesirable side-effect that 
phospho-Shc is also required for arteriogenesis.  Therefore, inhibiting phospho-
Shc may also prevent beneficial shear-induced collateral remodeling and 
decrease perfusion recovery in tissues with already-occluded vessels.   
 Another important future direction will be to assess the importance of Shc 
phosphorylation in the response to shear stress.  We have shown that shear 
stress induces Shc phosphorylation but is this phosphorylation required for 
association of Shc with the mechanosensory complex or for the activation of 
downstream signaling pathways such as NF-κB?  To test this we will utilize 
mutant Shc constructs in which the three tyrosine residues that are sites of 
phosphorylation (Y239, 240 and 317) are mutated to phenylalanine which cannot 
be phosphoryled (termed ShcY-F mutants).  We will transfect the Shc constructs 
into ECs and assay the response to shear stress in these mutant ECs.  We will 
assay Shc association with VE-Cadherin, VEGFR-2 and integrin β3 in response 
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 to shear stress as well as NF-κB activation and leukocyte adhesion to the 
endothelium after disturbed flow.  I hypothesize that ECs transfected with ShcY-F 
mutants will be unable to activate NF-κB in response to shear stress.  In 
conjuction with these proposed in vitro experiments to study the importance of 
Shc phosphorylation, we will perform in vivo experiments using transgenic mice 
that express the ShcY-F mutant downstream of a lox-STOP-lox cassette for 
conditional expression of the transgene46.  Currently, I am crossing Tie2-Cre 
mice to the ShcY-F mice in order to conditionally express the ShcY-F mutant in 
ECs.  These mice will be used in the atherosclerosis studies outlined above as 
well as in arteriogenesis studies in which the mice are subjected to femoral artery 
ligation surgery and hindlimb perfusion and collateral remodeling will be 
assessed.  In both models, I expect that the ShcY-F mutant mice will be unable 
to activate NF-κB and shear stress-induced inflammation; thus rendering the 
mice defective in atherosclerotic plaque formation and arteriogenesis. 
A second contribution that my research has made to the field of 
mechanotransduction is the novel observation that Shc is required for shear 
stress-induced activation of the Notch pathway.  Notch is a critical pathway in 
developmental biology as it controls cell-fate determination in many tissue types 
including the cardiovascular system 40, 41.  However, relatively little is known 
about the role of the Notch pathway in the adult cardiovascular system.  
Homozygous deletion of Notch-1 or the Notch ligands Dll-1, Dll-4 or Jag1 results 
in embryonic lethality due to cardiovascular defects.  Adult mice heterozygous for 
Notch-1 or Dll-1 exhibited reduced plantar perfusion recovery following femoral 
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 artery ligation, similar to the phenotype observed in Shc flox/flox; Tie2-Cre 
mice42, 43.  In vitro, shear stress has been shown to activate the Notch pathway in 
mouse embryonic stem cells in culture 44.  My work is the first to show that Shc is 
required for shear stress-induced Notch activation in vivo and in vitro in fully-
differentiated mouse ECs, which underlies arterial specification of the remodeling 
arteriole.  Previous studies suggested that the Notch pathway was activated 
downstream of VEGF, which is produced by ischemic tissue and drives 
angiogenesis.  However, my in vitro studies using serum-free normoxic 
conditions have shown that shear stress itself can activate the Notch pathway 
and result in upregulation of Notch target genes such as ephrinB2.  This begs 
several new questions regarding the mechanism explaining how Notch is 
activated by shear stress.  Notch is a transmembrane receptor that is activated 
when it binds to one of five ligands which are also transmembrane proteins that 
are expressed by a neighboring cell.  Binding of Notch to its ligand induces two 
proteolytic cleavage events by ADAM10 and then by the γ-secretase complex to 
release Notch Intracellular Domain (NICD) from the cell membrane and allowing 
it to translocate into the nucleus.  Once in the nucleus, NICD associates with the 
transcription factor CSL and activates transcription of a subset of genes including 
ephrinB2.  The idea that Notch is activated by shear stress is new and therefore 
it is unknown how mechanical force-induced Notch activation occurs.  One 
possibility is that shear stress upregulates expression of a Notch ligand which in 
turn activates Notch in trans through the canonical pathway.  Indeed, my 
preliminary data suggests that Notch ligands Dll-1 and Dll-4 are upregulated by 
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 shear stress in vitro, whereas these ligands are not upregulated in Shc flox/flox; 
Tie2-Cre ECs.  Future studies will confirm these preliminary results and use 
siRNAs to knockdown expression of Dll-1 and Dll-4 in ECs and assess Notch 
activation in response to shear stress to determine if expression of these two 
ligands drives Notch activation.  If Notch activation proceeds normally in Dll-1/Dll-
4 knockdown ECs, ligand-independent Notch activation may be occurring.  In this 
scenario, shear stress would activate γ-secretase directly, which in turn cleaves 
Notch and activates the Notch pathway.  Future studies will address the 
mechanism by which Notch is activated by shear stress and how Shc plays a role 
in this novel pathway for Notch activation by mechanical force. 
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 Figure 4.1: The adaptor protein Shc is a critical regulator of angiogenic and 
shear stress signaling in ECs 
 
The adaptor protein Shc regulates signaling from several receptors and is critical 
for many EC responses to their environment.  During angiogenesis, Shc 
mediates a subset of signaling from VEGFR-2 and fibronectin-binding integrins 
such as αvβ3 and/or α5β1.  In the context of mechanotransduction, Shc mediates 
signaling from the ‘Mechanosensory Complex’ and fibronectin-binding integrins 
that is activated by shear stress.  Collectively, Shc is required for many EC 
functions such as sprouting angiogenesis, migration, survival, inflammation and 
arterial specification.
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